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ABSTRACT 
A 3-Dimensional in Silico Test Bed for Radiofrequency Ablation Catheter Design Evaluation and 
Optimization 
Carolyn Teng 
Atrial fibrillation (AF) is the disordered activation of the atrial myocardium, a major cause of 
thrombogenesis and stroke. Currently, the most effective minimally traumatic treatment for AF is 
percutaneous catheter ablation to isolate arrhythmogenic areas from the rest of the atrium. The 
standard in vitro evaluation of ablation catheters through lesion studies is a resource intensive effort 
due to ablation substrate tissue variability and visual measurement methods, necessitating large 
sample sizes and multiple prototype builds. To address this, a computational test bed for ablation 
catheter evaluation was built in SolidWorks® using morphology and dimensions of the left atrium and 
adjacent structures. From this geometry, the physical model was built in COMSOL Multiphysics®, 
where a combination of laminar fluid flow, electrical currents, and bioheat transfer were used to 
simulate irrigated radiofrequency (RF) tissue ablation. Simulations in simplified 3D geometries led to 
lesion sizes within reported ranges from an in-vivo ablation study; however, while the ellipsoid 
morphologies in the full atrial model were consistent with past lesion studies, there were sizeable 
differences in lesion sizes. Perpendicularly oriented catheter tips were associated with decreases of -
91.3% and -70.0% in lesion depth and max diameter, while tangentially oriented catheter tips 
produced lesions that were off by -28.4% and +7.9% off for max depth and diameter. Preliminary 
investigation into the causes of the discrepancy were performed for fluid velocity, contact area, and 
other factors. Guided by the findings of these studies, suggestions for further investigation are 
provided to aid in root cause determination of this lesion discrepancy, such that the test bed may be 
verified for use for other ablation catheter evaluations.  
Keywords: Radiofrequency ablation, atrial fibrillation, computational modeling, catheter design. 
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Chapter 1 
INTRODUCTION 
1.1 Radiofrequency Catheter Ablation of Atrial Arrhythmias 
Radiofrequency ablation catheters are minimally invasive medical devices used to electrically 
pace and ablate cardiac tissue to treat arrhythmias. Of these arrhythmias, atrial fibrillation (AF) is the 
most prevalent. AF is caused by disordered activation of the atrial myocardium which leads to non-
coordinated contraction. Catheters for cardiovascular interventions are medical devices with steerable 
shafts made of flexible polymeric materials which are often structurally supported with wire 
coiling/braiding. They are used to deliver devices, drugs, fluids, or energy to treatment sites. Catheters 
enable physicians to perform interventions in locations that are difficult to access otherwise, with 
greater delicacy and precision. In ablation catheters, the distal end of the catheter is modified to have 
a tip that delivers thermal energy to the target tissues, as shown in [Figure 1].  
 
This energy can take the form of laser, ultrasound, cryofreezing, MRI, radiofrequency or 
microwave electromagnetic waves. Creating patterns of scar tissue can isolate and/or terminate 
aberrant electrical activity in the heart, returning functionality.  
1.2 Medical and Economic Burden of Atrial Fibrillation 
Atrial fibrillation is a widespread cardiovascular pathology: estimates indicate anywhere from 
2.7-6.1 million people in the United States have some stage of AF, with the prevalence expected to 
Figure 1. Schematic of (a) RF and (b) Cryoballoon Ablation Procedures to Treat Atrial Fibrillation.  
Image Credit: Calkins et al 2017. Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/)  
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rise to 12.1 million by 2030 [1]. This places a significant medical and economic burden on patients 
and the healthcare system, which already spends $6 billion on the treatment and management of AF 
annually. These trends are not just limited to the US or developing countries either; observations of 
global populations also reflect rapidly growing incidence and economic burden of AF [2]. While AF 
alone is not acutely fatal, it impacts mortality rates, exacerbates other chronic health conditions, and 
drastically impairs quality of life. 
Thromboembolism due to impaired contractile function of the atria is the major complication 
of AF [3], leading to a greatly increased stroke risk. Additionally, patients with AF tend to have worse 
outcomes (i.e. degree of disability, mortality rate) for ischemic strokes [4] [5]. In addition to stroke, this 
arrhythmia has also been linked with overall increases in mortality, risk of sudden death, heart failure, 
and the development of dementia [6], [7]. What makes this disease particularly pernicious is it’s 
frequently asymptomatic in its early stages [5], when intervention is most effective. Studies have 
suggested that asymptomatic AF is associated with similar or worse prognostic outcome compared to 
patients with symptomatic AF [8]. Part of the reason for this is the progression of the disease: AF leads 
to structural and electrical remodeling of heart tissues [3]. This exacerbates existing cardiac 
conditions—i.e. through decreased contractility, increased heart wall fibrosis, increased left atrial 
volume, and decreased left ventricular ejection fraction [9]—which in turn contributes to the spread 
and maintenance of the disease.  
  
3 
1.3 The Interventional Electrophysiology Device Market 
 Given the medical and economic burden of this disease, it is not surprising that the 
electrophysiology (EP) device market is large and growing. In 2017, the EP device sector was valued at 
$4.4 billion [10]. Additionally, this sector has maintained an impressive compound annual growth rate 
(CAGR) of 13% [11], ahead of many sectors in the medical device industry. With the aging of the 
population and ballooning number of AF patients in the next few decades, this field is expected to 
remain a critical area of investment and development for medical devices.   
1.4 Problem Statement 
The development of safe and effective ablation catheters increases the quality of patient 
outcomes while maintaining atrial functionality; however, ablation catheters can be difficult and 
expensive—in both time and resources—to research, design and test.  
1.4.1 Current Methods of Ablation Catheter Lesion Evaluation  
Most lesion evaluations consist of a tissue (or tissue substitute) placed in a heated bath of 
saline, then ablated with a catheter held in place with ~10-20 g of weight. The closest analogue to 
human cardiac tissue is porcine or bovine myocardium which is sliced apically to produce slabs of the 
ventricular myocardium for ablation studies. After ablation, the tissue is sectioned perpendicular to its 
surface and lesion dimensions are measured visually, with a ruler precision of ~0.5 mm, as illustrated 
in [Figure 2] [12].  
  
Figure 2. Measurement of Lesion Profiles After Tissue Ablation. 
Lesion identified by paler zone of protein coagulation. Image credit: Arenas et al 2014 [48]. 
Published under Creative Commons Attribution License 4.0 
(http://creativecommons.org/licenses/by/4.0)  
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These studies are used to characterize everything from catheter performance [13], 
temperature distributions, procedural factors influencing lesion formation [14], device quality, lesion 
geometry, control algorithms [15],[16], different electrode configurations [17] and much more. As 
expected, there is a lot of inherent variability in this testing procedure due to tissue inhomogeneity and 
visual assessment; therefore, to produce any statistically meaningful results, the sample size of 
studies needs to be large.  
 Gel phantoms made from agarose or polyacrylamide are an alternative ablation substrate 
used to reduce experimental variability [18]-[20]. These hydrogels typically contain a protein 
component that turns from translucent to opaque [21] or shifts colors [22] once it is denatured by the 
application of heat. In some gels, the electrical properties can be tuned with the titration of ionic 
compounds like sodium chloride. These gels are great tools for basic comparative experiments and 
catheter performance characterization, but while convection of blood across the ablation substrate 
surface can be mimicked with saline, there has yet to be a good way to recapitulate the perfusion 
effect present in living tissues.  
1.4.2 The Utility of Computational Models 
An alternative approach is the use of numerical methods like Finite Element Analysis (FEA) to 
simulate the physical situation. Variability in results are minimal, and many different metrics can be 
measured at a much finer resolution throughout the entire simulation space. These models aid in 
understanding the underlying physics of the ablation procedure physics; moreover, these simulations 
be helpful for device development and design, teaching tools or for procedural planning.  
1.4.3 Regulatory Stance on Computational Models 
 In the past, the FDA relegated such numerical studies as purely research and design tools; 
however, their viewpoint has recently shifted. Computational models may support medical device 
regulatory submissions, so long as they are accompanied by relevant validation studies [23]. 
Therefore, many individuals in the AF treatment pipeline—from researchers to design engineers to 
regulators and clinicians—can benefit from these in silico simulations.  
5 
1.5 Previous RF Ablation Computational Studies 
1.5.1 Literature Review 
Computational models are developed to bridge the gap between bioheat transfer theory and 
empirical experience with RF ablation devices. These simulations provide valuable insight into device 
design, procedural aspects, parameter selection for procedural planning [24], and other facets of RF 
ablation in silico. Early modelers primarily used FEA to verify the Penne’s Bioheat transfer model in a 
1D single domain [25]. Simple scenarios such as these are still used to test different models of 
Bioheat transfer, such as hyperbolic heat transfer [26]. With growing computing capability, 
experimental validation, and empirical data on material properties and device performance, 2D, 2D 
axisymmetric [27], [28], and 3D  geometries [29] have also come into use.   
One of the key developments in intracardiac ablation modelling was in assessing the cooling 
effect of blood on RF ablation. In early models, researchers chose to omit the blood volume, or treated 
it as a static blood pool [30]. Likewise, many neglected heat loss due to blood perfusion of tissues 
[14], [31], with the rationale that the heat losses were not significant. This assumption might not be 
appropriate for highly vascularized tissues like the myocardium. Jain and Wolf produced several 
papers on the FEA analysis and validation experiments, finding the effect of convective blood cooling 
significant enough to necessitate inclusion when building RF ablation models [32]-[36]. In these 
models, temperature rose faster and reached a greater magnitude with higher blood flow rates [39], 
[41], demonstrating lesion variability due to flow velocity. Further studies—both computational and 
experimental—went on to support these findings [38]. While not complex in theory, the coupled multi-
physics effect of heat transfer due to nearby fluid flow in multiple domains is computationally 
expensive to solve with numerical methods. Thus, many studies chose to approximate heat loss due to 
blood flow with a convective heat transfer boundary condition at the blood/electrode and blood/tissue 
interfaces.  
 Early uses of this convective heat transfer boundary condition include Min and Mehra [39], 
who applied Newton’s Law of Cooling (𝑄 = ℎ(𝑇௘௫௧ − 𝑇)) to solve for the heat flux between the tissue 
and blood. Text represented arterial blood temperature (i.e. 37 °C), T represented local temperature, 
and Q was the heat flux across the boundary [W/m2]. Values for h were determined experimentally 
6 
[41], [42], and included simple constant values as well as more complex versions of h. For example, h 
values were specialized for short ablation times [43], or for different blood velocities, vessel 
compositions and sizes [44]. Use of this boundary condition was tested against fluid flow in studies by 
Gonzalez-Suarez, Cao, and others; these studies found that the difference in lesion results were 
insignificant and mainly differed in asymmetry of lesion profile due to directional cooling [35], [37], 
[45], [46]. While use of this boundary condition didn’t overtly affect lesion performance, accurate 
estimation of blood temperatures during ablation was not possible [47]. Therefore, a convective 
boundary condition was adequate for lesion studies (e.g. [14], [41], [42], [44], [48], [49], [50]), but 
inadequate for predicting aspects like blood temperature distribution [51] or thrombus formation [47]. 
With the introduction of saline irrigation of catheter tips, modeling conjugate convective flow—the flow 
interaction of blood with structures—became even more necessary in numerical models of RF ablation 
[49], [45], [46], [52]. 
 Energy delivery methods have also varied across ablation studies. In clinical RF generators, 
electrical energy is output as a 500 kHz oscillating wave, with output power of up to 200 W. To 
facilitate solution of the electromagnetic heating in FEA simulations, physical approximations are 
made. The operating frequency range for RF devices means that the magnetic component of tissue 
heating is typically negligible; therefore, the resistive heating can be solved for quasi-statically. This is 
done by applying a constant voltage to the electrode surface, equivalent to the root-mean square 
(RMS) of the RF wave peak voltage (e.g. [14]). Furthermore, modelers like Haemmerich 2005 and 
2010 and Lai 2004 implemented control algorithms to mimic the function of commercial RF 
generators. These algorithms utilized proportional-integral-derivative (PID) programming feedback 
mechanisms to titrate power output based on intra-procedurally measurable factors such as 
temperature [15], [16], and impedance [53], [54].  
Although many models use constant electrical and thermal property values, tissue properties 
during ablation can change as a result of temperature, tissue inflammatory response, 
coagulation/desiccation, and water phase changes. As such, further studies examined the effect of 
parametric material properties during RF ablation. Tungjitkusolmun implemented temperature change 
using % change / ⁰C like relationships [55]. Lai et al 2004 and Cao and Paul et al also utilized 
temperature-dependent properties in their models [42], [37]. Arenas et al and Chen and Sidel made 
7 
use of damage-dependent perfusion to reproduce the local increase in perfusion over a temperature 
interval of 37 – 45 ⁰C, with a complete cessation of flow at 50 C due to tissue coagulations [44], [49]. 
Others like Gonzalez-Suarez et al 2015 and Watanabe 2010 used piecewise equations to model 
tissue electrical conductivity [46], [56]. Enthalpy methods have also been employed (e.g. [49], [46], 
[57]) to model liquid and gas phases of water; however, most other models terminated when 
temperatures exceeded 100 ⁰C.  
An aspect of RF ablation simulations that has seen little development in the past decade has 
been the incorporation of more realistic anatomical geometries. Almost all models utilize a simple 
tissue block with an adjacent blood volume. The catheter is placed orthogonal and inset into the tissue 
surface, while fluid flow (if included) runs parallel to the tissue surface. An example of this geometry is 
shown in the figure below [Figure 3].  
 
Figure 3. 2D Axisymmetric Model of Epicardial RF Ablation 
Image credit: Review article by Enrique Berjano, 2006. Image published under Creative Commons 
Attribution License 2.0 (http://creativecommons.org/license/by/2.0)  
 
For simple comparative and optimization studies for device design, this methodology is 
adequate to get meaningful results. One of the few published models that included more geometric 
complexity were the works of Berjano and Hornero, who studied esophageal damage during left atrial 
intracardiac ablation [59], [60]. Their 3D model included a chunk of the thoracic cavity around the left 
8 
atrium with bits of collateral tissues (i.e. lung, esophagus, aorta), as depicted in the image below 
[Figure 4].  
 
Figure 4. Anatomical Model to Study Esophageal Injury 
Image credit: Berjano and Hornero, 2005 [59]. Published under Creative Commons Attribution License 
2.0 (http://creativecommons.org/licenses/by/2.0).  
 
This enabled them to study power titration strategies to prevent thermal damage of the esophagus. In-
clinic, esophageal burns often leads to atrioesophageal fistula, a severe and frequently fatal adverse 
event.  
Anatomical realism in left atrial ablation models has not progressed much since then; 
however, studies for other RF ablation scenarios have adopted more morphologically realistic 
geometries as a means for procedural planning, preclinical testing, and patient personalization. 
Audigier et al reported on a hepatic tumor ablation model that utilized segmented image stacks and 
magnetic resonance imaging (MRI) flow studies to build a replica of the patient’s liver and associated 
major vasculature. This model was used to determine lesion formations in various regions of the liver, 
and validated by in vivo studies with adult pigs [61]. A particularly interesting outcome was the 
workflow that this group developed to allow for quick and personalized pre-procedural planning in 
clinic.  
9 
Although simplification of geometry is a necessary aspect of all FEA studies for reasons of 
practicality, Berjano et al and Audigier et al demonstrated that much could be gained from developing 
more anatomically relevant geometries for simulations. The bulk of realistic LA models are used in 
electrophysiology studies, where tissue composition and morphology are important to producing 
accurate activation and arrhythmia patterns of the atrial myocardium. Morphology is derived from 
segmented images of computed tomography (CT) or MRI, as well as histologic studies of fiber 
orientation [62], [63]. These models provide a great deal of insight into the initiation and termination 
of AF; yet for electrical and thermal studies, that level of realism is not necessary or practical to users 
like catheter design engineers. Thus, a balance between the simplicity of the tissue block and life-like 
atrial models, coupled with accurate electrical and thermal properties (i.e. parametric behavior) as 
well as a realistic blood cooling effect could provide a valuable tool in evaluating atrial ablations.   
1.6 The Proposed Model 
In this thesis, an anatomically relevant multi-physics computational model of left atrial ablation 
is presented. The intended use is as in silico test bed for catheter designs, allowing for evaluation of 
catheter performance and procedural aspects like collateral damage.  
1.6.1 Thesis Aims 
This thesis addresses the following questions: 
1) Can a biophysical model of AF ablation be developed in COMSOL Multiphysics? 
2) Can relevant metrics of RF ablation be evaluated from this model and compared to literature? 
3) Can an anatomically relevant 3D model of the left atrium be developed using solid-modeling 
software/computer-aided design (CAD)? 
4) Can the biophysical model for AF ablation be applied to the expanded anatomical model? 
1.7 Summary of Contents 
First, Chapter 2 provides an overview of the anatomy, pathophysiology, and medical 
management of atrial fibrillation. Chapter 3 lays out the theory behind the Bioheat transfer used to 
develop the multi-physics model. Chapter 4 presents the model development process, including: 
geometry, applied boundary conditions, material models, etc. In Chapter 5, the results of the 
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simulations are reported, including mesh convergence and model validation versus literature. Chapter 
6 discusses the significance of these results, limitations, and future directions. Finally, Chapter 7 
summarizes major conclusions and recommendations based on the findings of this thesis.  
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Chapter 2 
ANATOMY & PHYSIOLOGY OF THE LEFT ATRIUM AND ATRIAL FIBRILLATION 
2.1 Normal Function of the Heart 
 The left atrium is a chamber of the heart located above the left ventricle which receives 
oxygenated blood from the lungs via a set of 4-5 pulmonary veins. While blood flows from the left 
atrium to the left ventricle, it through the mitral valve. The mitral valve is seated in elliptical ring of 
tissue call the mitral annulus (~ 3 cm major axis; 2 cm minor axis). For the majority of the cardiac 
atrial activation cycle, blood flows passively through the atria to the ventricles. The atria are only active 
for 15% of the atria cycle [64]—which encompasses depolarization by the sinoatrial node---providing 
~20% of the total blood volume into the ventricles prior to the closure of the mitral valve [3]. During 
systolic contraction, the blood back pressure of the ventricles closes the mitral valve, and the blood is 
ejected out through the aortic valve into the systemic circulation. This circuit is illustrated in [Figure 5]. 
 
Figure 5. Dissected 4 Chamber View of Cardiac Anatomy.  
Arrows indicate the direction of blood flow. Image credit: Wapcaplet. Graphic published under the 
Creative Commons Attribution-Share Alike 3.0 Unported license 
(https://creativecommons.org/licenses/by-sa/3.0/deed.en).   
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The pulmonary veins are located on the posterior wall of the left atrium, and are identified by 
their direction relative to the atria as they connect from the lungs. In most individuals, there are four 
main pulmonary veins—the right superior (RSPV), the right inferior (RIPV), the left superior (LSPV), and 
the left inferior (LIPV)—with several frequently observed variations. For example, the ipsilateral veins 
may share a common trunk, or there may be a third middle vein between the superior and inferior 
branches. Typical diameters for the PVs are ~13 mm, with the superior PVs having a larger diameter 
than that of the inferior PVs. Wall thickness of PVs proximal to the atria is ~0.50 mm [65]. Each set of 
right and left pulmonary veins is usually joined by a thickened ridge of tissue known as the pulmonary 
sinus. The tissue surrounding the pulmonary vein openings is called the PV ostium. Major anatomic 
landmarks of the left atrium are depicted in [Figure 6].   
 
Figure 6. Left Anterior View of Dissected Left and Right Atria.  
Image credit: Carolyn Teng. Resources referenced: [66], [67], [68].  
During normal sinus rhythm, excitation of the heart originates in the cells of the sinoatrial node 
located at the apex of the right atrium. The depolarization of contractile cells spreads through the right 
and left atria, then converges on the atrioventricular node. Activation of the atria causes their walls to 
contract, pumping blood into their respective ventricles. The conduction velocity of the depolarization 
wave is slightly delayed at the AV node, after which it races down the Bundle of His, then out to the 
Purkinje fibers which activate the ventricular myocardium.  
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2.2 Etiology of Atrial Fibrillation 
Atrial fibrillation (AF) is the uncoordinated activation of the atrial myocardium which leads to 
impaired atrial contractility. The exact initiation of AF is still the subject of debate; however, what is 
generally agreed upon are the conditions necessary for its initiation and maintenance. That is, the 
triggering event must also be accompanied by a pro-fibrillatory tissue substrate for AF and other 
arrhythmias to occur. Contributing factors include the histological makeup of the atrial walls, the 
innervation and/or automaticity of anatomical structures, and the function of the transmembrane ion 
channels that govern conduction and contraction of the heart [3], [69]. 
2.2.1 Causes 
Abnormal spontaneous activity (a.k.a. focal ectopic firing) and reentry currents are the two 
major causes of arrhythmia [3], [70]. The predominant source of aberrant potentials in AF comes from 
the muscular sleeves of the PVs. These muscle cells are responsible for the dilation and contraction of 
the PVs to control flow, as a throttle valve might in a mechanical fluid transport system. However, 
because they are self-activating, the depolarization waves they generate can escape from the PVs into 
the greater atria, as depicted in [Figure 7].  
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As these potentials occur at a much higher frequency than those generated by the sinus 
node, they can interfere with normal activation of the atrial myocardium. For example, they might 
collide with and terminate the depolarization wavefronts from the SA node, or prematurely excite the 
tissues ahead of these wavefronts, blocking normal conduction. Alternatively, if the gap between 
potentials during sinus rhythm is long enough, these potentials may cause early and/or off-beat atrial 
activation. Thus, different sections of the tissue in the atrium could be activated out of sync with 
adjacent tissues. 
A separate but sometimes concurrent arrhythmogenic phenomenon are re-entry currents. 
Cardiomyocyte depolarization is mediated by a sequence of voltage-gated and active transmembrane 
channels, which facilitate the flow of ions across the cell membrane to generate an electric current. 
This current propagates through the cells to adjoining cells. Once depolarized, the cell requires a 
period of time for ion pumps to return the cardiomyocyte back to its resting electrical potential. This is 
known as the refractory period. During this period, further stimulus to the cell does not trigger 
depolarization. Re-entries typically arise when there is a difference in conduction rates through 
Figure 7. Theories on the Mechanisms of Atrial Fibrillation.   
a) Multiple wavelets hypothesis, b) automatic foci, c) single reentrant circuit with fibrillatory conduction, 
d) functional reentry, and e) AF maintenance due to dissociation between epicardial and endocardial 
layers. Image credit: Calkins et al 2017 [69]. Published under Creative Commons Attribution 4.0 
International License (http://creativecommons.org/licenses/by/4.0/). 
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adjacent tissues. After the passage of the “fast” wave of depolarization, the “slow” wave of 
depolarization is blocked from further progression by the resetting of the cells activated by the “fast” 
wave. If the originating tissues have sufficient time to repolarize, the wavefront loops back around 
instead of terminating. This forms what is known as a circus reentry or rotor [Figure 7a, 7c, 7d]. 
Additional factors that lead to arrhythmia formation include decreased conduction velocity, decreased 
atrial refractoriness, unidirectional block, or increased dispersion [7]. [69]. Re-entry currents 
sometimes “anchor” themselves around an anatomical structure; in the left atrium, a common anchor 
structure is the pulmonary vein opening. 
2.2.2 Risk Factors 
 There are multiple congenital, pathological and lifestyle factors that contribute to increased 
AF risk. Incidences of AF tend to crop up after cardiovascular events and diseases, such as myocardial 
infarction, high blood pressure, valve disease, sick sinus syndrome, or congenital heart defects. Other 
health conditions that contribute to AF include endocrine diseases (e.g. diabetes or hyperthyroidism), 
pulmonary disorders (e.g. chronic obstructive pulmonary disease, obstructive sleep apnea), and 
lifestyle choices like excess alcohol and caffeine consumption [3],[7], [69]. Many of these risk factors 
are associated with an increased cardiac burden (i.e. higher preload, hypertension, etc.), which leads 
to progressive structural and electrical remodeling, fibrosis, and atrial enlargement [3]. Because of 
this, most AF patients (~90%) have some form of concurrent cardiovascular disease, such as 
hypertension, coronary heart disease, valvular heart disease, dilated cardiomyopathy, pericarditis or 
heart failure [69]. These conditions primarily lead to an increase in fibrosis, which obstructs or 
complicates conductivity of the myocardium. 
2.3 Pathophysiology of Atrial Fibrillation 
2.3.1 Symptoms 
Symptoms for AF include: irregular heartbeat, heart palpitations, dizziness / lightheadedness, 
shortness of breath, fatigue, angina, syncope, and confusion. Many of these symptoms are linked to 
reduced stroke volume and/or increased pulmonary circuit load.  
2.3.2 Disease Progression 
The classifications for severity of AF are outlined by the AHA/EHS consensus statement [1] as follows: 
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 First detected: 1 diagnosed episode 
 Recurrent: 2+ diagnosed episodes 
 Paroxysmal: Self-terminating in <7 days 
 Persistent: Fibrillatory episodes last > 7 days 
 Permanent: long-term or chronic fibrillation 
While these classifications are primarily for diagnostic purposes, they loosely correlate with the 
progression of the disease. Fibrillation leads to structural and electrical remodeling (slowed 
conduction, fibrosis, unidirectional block, etc.), which begets longer and more frequent fibrillatory 
episodes [7]. As the disease progresses, the tissues making up the atria become more histologically 
and electrically complex [3], [7], making it difficult for the natural termination of fibrillation and 
reestablishment of sinus rhythm. 
2.3.3 Prognosis 
With proper rhythm and thromboembolism management, AF alone is not usually fatal. 
Progression of AF to later stages—in which fibrillatory episodes are more frequent and sustained—
poses a greater risk of thrombus generation. One study found that ~25% of patients with paroxysmal 
or persistent AF developed more severe forms of AF within a 1.5 year follow up period [72]. AF 
dramatically increases the risk of ischemic stroke: up to 5x that of non-AF patients [7]. The strokes 
caused by AF tend to be more severe than typical strokes, with the risk of serious disability and death 
3-months following the ischemic event estimated at 50% and 60%, respectively [5]. AF is also 
associated with up to a 30% higher risk of cardiovascular events (i.e. congestive heart failure, left 
ventricular dysfunction, mortality, myocardial infarctions) compared to patients in sinus rhythm [7], 
[64], [73]. Therefore, proper treatment in earlier stages can help mitigate these risks.  
2.4 Treatments for Atrial Fibrillation 
 Treatments for AF include both pharmacological and surgical interventions. The anti-
arrhythmic drugs (AADs) are broken up into rate and rhythm control drugs. Rate control therapy is a 
ventricular -focused approach that limits sinus activation rates (<100 BPM) to decrease the burden on 
the heart. This method aims to preserve heart tissue and slow the destructive progression of 
cardiovascular disease [74], and are also used in the management of other arrhythmias as well as 
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myocardial and coronary diseases. Still, these drugs only treat the functional consequences rather 
than the source of AF [3]. The objective of rhythm control drugs is to restore and maintain a normal 
sinus rhythm. Meta-analyses of rhythm versus rate control drugs have found no significant difference 
between the efficacy of these drugs [75], [76], but there has been evidence of increased risk of 
adverse events with rhythm-control drugs versus rate control drugs [75], [77]. Moreover, efficacy of 
these drugs is low, with one meta-analysis reporting AF free survival at 12 months of 18.8% vs 75.7% 
for surgical intervention [77]. The lack of efficacy coupled with the risk of severe side effects means 
that patients unresponsive to the drugs are referred for more direct interventions. 
 In the 1980’s, the Cox-Maze procedure was developed to help isolate the rogue stimuli 
causing AF. This open-chest procedure involved cutting the atria into sections, then suturing them 
back together. The resulting scar tissue at each of the joins formed insulative lesion lines. Though 
invasive, the Cox-Maze procedure had remarkably high rates of success. Some studies reported long-
term freedom from AF rates at 75-85%, depending on the lesion pattern used [67]. Over the past 3 
decades, the focus has largely shifted to recapitulating the success of the Cox-Maze procedure with 
minimally invasive interventions. Instead of open surgery, lesions are created via ablation using 
specialized percutaneous catheters. The Cox-Maze procedure is still being used—sometimes in concert 
with RF ablations—to treat persistent and more advanced stages of AF. 
 These steerable catheters are inserted into the patient’s vasculature via the femoral or 
axillary vein and navigated through either the inferior vena cava or superior vena cava to the heart 
(respectively). To access the left atrium, a puncture is made in the interatrial septum at the location of 
the foramen ovale. Through this port, electrical mapping and ablation catheters can be passed 
through. Upon deployment to the target tissues, the catheters deliver energy to the atrial wall. This 
causes local tissue death via hyper- or hypothermia—depending upon the technology used—and the 
formation of insulating lesions, isolating arrhythmogenic areas such as the pulmonary veins [71], [78].  
2.5 Anatomical Considerations for Atrial Fibrillation Ablation 
2.5.1 Targets for Ablation: Pulmonary Veins 
 PVs are a key arrhythmogenic anatomical feature in the left atrium and are the primary target 
for ablation during intracardiac catheter ablation of AF. There are several lesion sets employed for 
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isolation of the PVs (i.e. segmental/ostial, circumferential, circumferential/antral) [71], [78] [Figure 8]; 
however, the ultimate goal of all of these patterns is to form a continuous transmural lesion around 
the PV openings to prevent propagation of the pulmonary vein potentials (PVPs) from spreading. Direct 
ablation of the PV opening is not ideal, as it has the potential to cause PV stenosis. This narrowing of 
the PV diameter can lead to pulmonary hypertension and ventricular decompensation [3]. Hence, the 
isolation patterns can cross large portions of the atrial myocardium, as shown in the following figure 
[Figure 8].  
 
 
 
Figure 8. Common Lesion Patterns in Catheter Ablation of Atrial Fibrillation.  
(a) Circumferential, (b) circumferential + antral, (c) circumferential, ipsilateral, roofline, mitral 
isthmus, and (d) focal electrogram guided ablation patterns. Image Credit: Calkins et al 
2017. Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/)  
 
2.5.2 Targets for Ablation: Non-Pulmonary Vein Structures 
 Depending on the stage and complexity of the AF, other aspects of the atrial anatomy might 
be targeted during catheter ablation. Generally, these take the form of linear lesions across the lateral 
atrial posterior free wall, the posterolateral left atrial ridge and the mitral isthmus. Some surgeons may 
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also isolate the left atrial appendage and the superior vena cava. If remaining aberrant potentials 
persist, the electrogram (a spatially correlated measure of intracardiac electrical activity, like an ECG) 
is referenced to try to locate the source of the focal potentials and eliminate them [78]. Examples of 
these lesion sets are depicted in [Figure 8b, Figure 8c]. Choice of additional ablation is guided by 
physician experience and mapping catheter capabilities.   
2.5.3 Transmurality + The Importance of Atrial Wall Thickness 
 Successful electrical isolation requires transmural lesions—lesions that cross the entirety of 
the atrial wall thickness. Problematically, wall thickness is not uniform and can vary greatly within 
patients, between patients, and between measurement modalities (i.e. ex vivo, CT, MRI). For example, 
in a LaPlacian assisted segmentation of CT left atrial wall thickness, one group found an average wall 
thickness of 0.6 -1.0 mm, although values ranged from 0.5 – 5.0 mm [79]. Another study which relied 
on dissection and manual measurement of excised hearts found that for patients >50 years of age 
whose primary cause of death was not due to cardiac pathology, average wall thickness was 2.09 ± 
0.89 mm for the anterior LA, 1.25 ± 0.31 mm for the posterior LA, 1.33 ± 1.46 mm for the LAA, 1.75 ± 
0.29 mm for RA, and 1.31± 0.36 mm for RAA. There was up to ± 50% standard deviation spread from 
mean measurements. In this study, researchers proposed that the high degree of inter-donor 
variability could be attributed to both anthropomorphic variability as well as concurrent illnesses which 
could alter anatomical structures [80].  
 In the cases of PV reconnection (unsuccessful isolation), the most common culprits are the 
PV-left anterior appendage ridge on the left roof and the intervenous ridge [81]. These thick muscular 
ridges pose an issue because they require more power to achieve transmurality and make it difficult 
for the physician to place the catheter flush with the tissue. On the other hand, overestimating the 
thickness of the atrial wall has its own issues. Thin atrial walls are especially susceptible to 
intracardiac trauma, such as cardiac tamponade or perforation by the catheter tip. These adverse 
events may require open surgery to fix, further increasing the health risk for the patient. While 
guidewire-assisted navigation and placement of catheters can mediate some of this risk, the delicate 
anatomy is still at risk due to the potential for over-deposition of RF power, which could cause 
excessive damage to collateral tissues.  
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2.5.4 Collateral Damage Risks 
 Thermal damage to adjacent anatomical structures is of critical concern in left atrial 
ablations, as there are many structures in close proximity to the target area. Structures including the 
esophagus, descending aorta, phrenic nerve, and vagal nerve all pass within close proximity to the 
posterior wall of the left atrium, as shown in [Figure 9].  
 
Figure 9. Heart Positioning Within the Thoracic Cavity.  
Sagittal view depicts proximity of the esophagus thoracic aorta to the posterior wall of the left atrium. 
Image credit: Dongho Kim [82]. Licensed as Creative Commons Attribution-Non-Commercial-
ShareAlike 4.0 International. (https://www.oercommons.org/authoring/18546-heart-anatomy/view#). 
 
This area of the atrium has particularly thin walls compared with the rest of the chamber. The phrenic 
nerve innervates the diaphragm, while the vagal nerve innervates the heart, lungs, and digestive tract 
down to the colon. Although these neurons are primarily sensory and communicate the status of 
organs to and from the brain, damage to the phrenic nerve could result in rapid or labored breathing, 
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coughing, or hiccups. Damage to the vagal nerve can result in heartburn, difficulty swallowing, nausea, 
bloating, and constipation [83]. While these injuries are relatively minor and may resolve on their own, 
there are more severe consequences to collateral damage during ablations that are often debilitating 
and/or fatal. 
 For example, a major and lethal complication of ablation procedures is the atrioesophageal 
fistula. The esophagus descends close to the posterior wall of the left atrium. During ablation of the 
PVs and posterior wall, heat can propagate to the esophagus, causing trauma and an unnatural 
connection between the esophagus and left atrium. This opening leads to air embolism, pericardial 
effusion, hemorrhaging, bacterial infection leading to rapid sepsis, and death. Current practice is to 
minimize power on the posterior wall of the atria to minimize risk of esophageal damage or 
atrioesophageal fistula formation [84]. Researchers and clinicians suspect that a small 
endocardium/esophageal distance and the absence of fibrofatty connective tissue between the 
myocardium and the esophageal wall may increase the risk of this complication [85]. As such, pre-
procedural planning must consider BMI on top of age, thromboembolic risk, and concomitant 
cardiovascular diseases.  
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Chapter 3 
BIOPHYSICS OF RADIOFREQUENCY ABLATION 
3.1 Overview of Relevant Physics 
Radiofrequency lesions in tissue are formed when alternating electrical current at ~500 kHz 
(range: 10 – 2000 kHz) is transmitted from a metal tipped electrode to a dispersive ground electrode 
adhered on the patient’s back or leg. As power transits from the ablation site to the grounding 
electrode, it transfers energy to the intermediary tissues through the process of Joule (resistive) 
heating. Due to the high surface area mismatch between the dispersive electrode and the active 
electrode, the current density and consequently the power deposition is high adjacent to the catheter 
tip. The electrical potential drops rapidly--proportional to 1/r where r is the radial distance from the 
electrode surface—therefore, only a thin section of tissue adjacent to the electrode is heated directly. 
This heat then propagates to surrounding tissues via thermal conduction.  
 Tissues experience irreversible damage (i.e. protein coagulation, desiccation, and char) at ≥ 
50 °C, resulting in the formation of a lesion (i.e. injury). The type of damage is temperature 
dependent: coagulation dominates from 35-60 °C, desiccation occurs from 60 – 100 °C, and 
char/carbonization of tissue happens at temperatures above 100 °C [86]. The necrotic tissue of the 
lesion—and later the fibrotic scar tissue—lacks the excitability and conductivity of muscle or nerve 
cells, hence terminating any activation waves that hit it. By insulating the healthy tissues from the 
aberrant currents, normal rhythm can be restored with minimal loss of function to the overall cardiac 
chamber. 
 There are several effluxes of heat from the system, as illustrated in [Figure 10]. A portion of 
the heating during ablation is lost to perfusion of the tissues, whether via capillary bed or through 
adjacent vessels. Additionally, convective heat loss occurs at the blood/tissue and blood/electrode 
interfaces. The degree to which heat is lost to either blood volume, be it intracardiac or 
epicardial/intramuscular is dependent on the catheter location within the heart and the blood velocity 
at the ablation site. 
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 To prolong RF deposition for the creation of larger lesions and to avoid adverse events, many 
catheter designs include irrigation of the tip. There are two types of irrigated catheters: closed loop 
irrigation, and open irrigation. Open-irrigated catheters contain several irrigation port holes located in 
the electrode tip through which room temperature heparinized saline is pumped to cool the tip. The 
fluid motion and cooling effect of this saline fluid flow prevents coagulum formation and steam pops, 
and enables further current deposition [87]. These events are of concern due to the associated 
thromboembolic and cardiac perforation risk, respectively. Moreover, they tend to be self-
exacerbating: insulating coagulum decreases the usable surface area of the electrode, resulting in 
higher current densities which lead to more intense local heating. Local temperatures may exceed 
100 °C, which results in the liquid-to-gas transition of water vapor in the blood and in tissues, 
producing tiny explosions that can be heard as an audible pop. If this expansion happens within the 
tissues, this could lead to perforation. Deposition of RF current can be halted by a rapid impedance 
Figure 10. Heat Transfer Vectors in RF Ablation.  
Green = heat efflux due to capillary perfusion. Blue = heat efflux due to 20 °C saline irrigation. 
Yellow = heat efflux due to blood convection over the tissue surface. Orange = heat transfer due 
to conduction to adjacent media.  
Qconvection 
Qirrigation 
Qconduction 
Qperfusion 
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rise induced by insulative material on either the catheter tip (coagulum) or tissue (char) surfaces, or 
the formation of water vapor.  
3.2 Mathematical Models of Ablation Biophysics 
3.2.1 Heat Transfer: Pennes’ Bioheat Equation 
Heat transfer in biological tissues is often described by the Pennes’ bioheat transfer equation: 
a derivation of Fourier’s law of thermal conduction where the rate of heat transfer through a material 
as a function of the thermal conductivity of the material and the negative gradient in the temperature, 
as shown below  
 ?⃗? =  −𝑘∇ሬ⃗ 𝑇 
where ?⃗? is the heat transfer, 𝑘 is the thermal conductivity of the participating material, and ∇ሬ⃗ 𝑇 is the 
gradient of temperature normal to the isotherms within the material. Each expression within the 
Pennes’ bioheat equation represents the individual components of heat flux due to blood convection 
and tissue perfusion and heat sources, as shown in the equation below.  
𝜌்𝐶௣,்
𝜕𝑇
𝜕𝑡
+ 𝜌஻𝐶௣,஻𝑢ሬ⃗ ∙ ∇𝑇 = ∇ ∙ ?⃑? + 𝑄௘ + 𝑞଴ + 𝑄௕௜௢ 
The left hand side (l.h.s.) expressions represent the time-varying heat distribution of the tissue (1st 
term, l.h.s.), the heat flux due to blood flow (2nd term, l.h.s.), where 𝜌் is the density of tissue [kg/m3], 
𝐶௣,் is the specific heat of tissue [J/kg · K], 
డ்
డ௧
 is the time-varying temperature gradient [K/s], 𝑢ሬ⃑  is the 
velocity field, 𝜌஻ is blood density, 𝐶௣,஻ is the specific heat of blood and 𝑇 is the local temperature. On 
the right-hand side (r.h.s.) the expressions represent the conductive heat flux (1st term, r.h.s.), 
resistive heat flux (2nd term, r.h.s.), any initial heat fluxes (3rd term, r.h.s.), and the biologic heat flux 
in living tissue substrates (4th term, r.h.s.). 𝑄௕௜௢ is a combination of heat flux due to perfusion and the 
metabolic heat generation, given by the following equation: 
𝑄௕௜௢ = −𝜌௕𝜔௕𝑐௕ ∙ (𝑇௕ − 𝑇) + 𝑄௠௘௧   
where 𝜌஻  is the density of blood [kg/m3], 𝐶௣, 𝐵 is the specific heat of blood [J/kg · K], 𝜔் is the 
perfusion rate of tissue, and 𝑇௕ − 𝑇  Is the temperature difference between arterial blood temperature 
(37 °C) and local tissue temperature in [K]. The metabolic heat generation Qmet is usually neglected, 
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as it is much smaller in magnitude than the other terms [16], [23], [26], [34], [35], [41], [43], [45], 
[46], [79], [80]–[82].  
3.2.1.1 Joule (Resistive) Heating 
Resistive losses of the tissue when exposed to RF electromagnetic energy causes heating 
during RF ablation. The heat flux due to EM fields is given by 
𝑄௘ = 𝑄௥௛ + 𝑄௠௟  
where Qrh and Qml represent the resistive and magnetic heating components respectively. At 
frequencies of 500 kHz, the contribution of magnetic heating is negligible, thus Qe becomes solely a 
function of resistive losses. This allows for a quasi-static approximation of the electrical heating. 
The magnitude of the resistive heating is given by 
𝑄௥௛ =
1
2
𝑅𝑐(𝐽 ∙ 𝐸ሬ⃗ ) 
where 𝑄௥௛ is the distributed heat source [W], 𝑅 is the universal gas constant [J/mol · K], 𝑐 is the speed 
of light in a vacuum [m/s], 𝐽 is the current density [A/m2], and 𝐸ሬ⃗  is the electric field [V/m]. The current 
density and electric field are calculated as 𝐽 = (𝜎 + 𝑗𝜔𝜀଴𝜀௥)𝐸ሬ⃑ +  𝐽௘ሬሬ⃑ and 𝐸ሬ⃑ =  −∇𝑉, where 𝜎 is the 
electrical conductivity [S/m], 𝜔 is the frequency of the EM wave [Hz], 𝜀଴𝜀௥ is the permittivity of free 
space multiplied by the relative permittivity, and 𝑉 is the electrical potential. The Laplace equation is 
used to solve for the voltage and is given by ∇ ∙ 𝜎∇𝑉 = 0. Additionally, the current through a system is 
solved for using the integral form of Ampere’s Law 𝐼 =  ∮ 𝐽 ∙ 𝑑𝑠. 
3.2.2 Mass Transfer: Navier Stokes 
The Navier-Stokes equation for an incompressible Newtonian fluid is used to solve for the 
velocity field in the convective heat loss term, and is defined as by the momentum and conservation of 
mass equations: 
𝜌
𝜕𝑢ሬ⃗
𝑑𝑡
+  𝜌𝑢ሬ⃗ ∙ ∇𝑢ሬ⃗ = −∇𝑃 + 𝜇∇ଶ𝑢ሬ⃑ + ?⃑? 
∇ ∙ 𝑢ሬ⃗ = 0 
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where 𝑢ሬ⃗  is the velocity field [m/s], ρ is the density of the fluid [kg/m3], −∇𝑃 is the pressure gradient, 𝜇 
is the viscosity [Pa · s], and ?⃑? is the body force due to gravity. This equation describes flow as a 
function of convection, gravity, pressure, and viscous drag.  
3.3 Tissue Viability: The Arrhenius Damage Equation 
 Most models of hyperthermic therapies employ a 50 °C isotherm as the estimated lesion 
area, which is roughly the temperature that induces visible injury in tissue during lesion studies. In 
COMSOL Multiphysics®, there are two methods of time-dependent damage characterization methods: 
the (1) temperature-threshold, and the (2) Arrhenius damage integral. The temperature-based method 
specifies damage onset and necrosis temperatures, as well as an exposure time to full irreversible 
damage. The preset thresholds for hyperthermia ablations are coagulation at 50 °C, full necrosis at 
100 °C, and the time to full damage is 50 seconds over the 50 °C threshold. The Arrhenius damage 
integral calculates damage as a function of energy absorption, and is based on the activation energy 
of the damage processes (i.e. protein coagulation) and energy absorption of the biological tissue. The 
equation is as follows: 
Ω(𝜏) = 𝑙𝑛 ቈ
𝐶(0)
𝐶(𝜏)
቉ = න 𝐴𝑒(ି
ா
ோ்(௧))
ఛ
଴
𝑑𝑡 
where Ω is the total damage, E is the activation energy of the target process (in this case, protein 
coagulation), ஼(଴)
஼(ఛ)
 is the fraction of undamaged tissue, R is the universal gas constant, and T(t) is the 
temperature as a function of time. Activation energy is tissue-dependent, with the value for 
myocardium reported as 1.62 E 6 J/mol [88]. In both modalities, damage is computed as a fraction of 
necrotic tissue and is represented by the symbol Ω. Damage values run from 0 to 1, where a value of 
0 represents no necrosis (i.e. 100% healthy tissue), and 1 represents total, irreversible tissue damage.  
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Chapter 4 
MODEL DEVELOPMENT 
 Modeling the Catheter Tip of the Test Device  
For this study, a catheter tip modeled based on BioSense Webster’s Navistar Thermocool® 
7.5 Fr RF ablation catheter was drafted using SolidWorks® solid modeling software. The tip has a 
barrel diameter of 2.5 mm, and a length of 3.5 mm. This catheter model features six (6) irrigation 
ports, with a diameter of 0.5 mm [Figure 11].  
 
To simplify the device geometry, irrigation ports and the catheter tip were modeled as surfaces rather 
than solid. Given enough design knowledge and a more computational resources, such detail could be 
included. 
 Physics and Material Properties Verification through Simplified Models 
 Several iterations of the ablation scenario with increasing geometric complexity were 
developed to verify the physics, boundary conditions, and material properties prior to implementation 
in the full left atrial anatomical model. Both the 2D and simplified 3D models consisted of a 7.5 Fr 
(2.5 mm OD) ablation catheter tip on a myocardial tissue block, with a blood volume above the tissue 
surface. Models were built with the catheter tip in a perpendicular and parallel configuration in 
relation to the tissue surface. For the perpendicular tip orientation, the catheter tip was inset 0.5 mm 
Figure 11. Model of BioSense Webster Navistar Thermocool® 7.5 Fr Ablation Catheter, Created in 
SolidWorks®.  
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into the tissue block with a conical depression to simulate the tissue tenting due to tip contact force. 
Blood flow of 0.13 m/s across this model was used to approximate the left atrial flow conditions [89]. 
 In the 2D model, the irrigation ports were simulated with using an edge with a length of 0.5 
mm, commensurate with the diameter of the irrigation ports on the chosen catheter. These ports were 
located 1 mm from the distal tip of the electrode. The 2D geometry and irrigation port placement are 
displayed in the following figure [Figure 12]. 
  
For the 3D model, an array of circular faces interspersed 60 degrees apart were propagated on the tip 
electrode exterior. The catheter domain was differenced off from the solution domain in the 3D model 
to reduce mesh sizing and solution times. Furthermore, a spherical subdomain encompassed the 
Figure 12. Geometry of 2D Model Used for Physics and Properties Verification. 
Catheter tip inset at a depth of 0.5 mm. Irrigation ports modeled as line segments with a 
length of 0.5 mm. Tip diameter was 2.5 mm, and tip length was 3.5 mm. Catheter tip 
placed at interface between blood (top) and tissue (bottom) domains. 
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catheter tip, which was used for mesh control purposes, as is described in more detail later in this 
chapter. Images of each simplified model are included in [Figure 13].  
  
 Several types of convergence studies were performed to determine appropriate sizing of the 
tissue block and the study region, following the practices of past models in this field. The electrical 
gradient in the simulated ablations was highly dependent on the separation distance between the tip 
electrode and the ground boundary condition due to the summed impedance of the tissue between 
them. Iterative simulations were performed with tissue depths from 20 – 60 mm. Of the simulation 
depths, 50 mm produced lesions that were closest to the maximum lesion depth of 9.3 mm reported 
by Moreno et al for the same ablation parameters. Images of the temperature distributions and 
electric field norms for each tissue thickness can be found in [Appendix A].  
 
Figure 13. Simple 3D Ablation Simulation Model 
Catheter tip oriented (a) perpendicular and (b) parallel to the tissue surface. The spherical 
subdomain allowed for custom mesh biasing. The perpendicular simulation featured a conical 
insertion region which mimicked tissue tenting due to contact force.  
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 Left Atrial Anatomical Model Geometry 
4.3.1 Left Atrial Anatomic Modeling Approaches 
Models were built Fusion 360®, SolidWorks®, and COMSOL® MultiPhysics’ native CAD 
environment, with varying degrees of morphological realism and computational suitability. Images of 
these early iterations of the model geometry can be found in these appendices: [Appendix B, Appendix 
C, Appendix D, Appendix E]. The final left atrial anatomical model was built in SolidWorks®. The 
primary advantages of this CAD software were easy specification and customizability of dimensions, 
an extensive set of primitive geometries and modeling tools, as well as the ability to define and 
manipulate assemblies. 
4.3.2 Critical Anatomic Features of the Left Atrium 
A central aspect of this thesis was in generating a more anatomically relevant left atrial 
anatomical geometry for testing ablation catheter tips that was compatible with COMSOL Multiphysics. 
Simplified left atrial geometry and procedurally relevant adjacent structures were generated using 
solid modeling. Dissection studies, computed tomography (CT) images, magnetic resonance imaging 
(MRI) stacks, and medical illustrations guided the overall morphology and positioning of the tissues.  
 The primary atrial features for this model included 4 pulmonary veins which inserted into the 
posterior wall of the left atrium, and the mitral valve annulus at the bottom end. While there are many 
anatomical variations of the atrio-venous junction, as depicted in [Figure 14], the configuration of four 
PVs is the most common type seen in humans and was included in this model.  
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Figure 14. Posterior View of Left Atrium, Reconstructed from CT/MRI Data.  
Several possible configurations of pulmonary vein entry into the left atrium. Upper left image (a) 
represents the most common, 4 PV branch configuration. Image credit: Calkins et al 2017 [73]. 
Published under the Creative Commons Attribution 4.0 International License (http:// 
creativecommons.org/licenses/by/4.0/).  
 
Furthermore, inclusion of the esophagus was deemed important to assessing procedural 
safety. The aorta and esophagus were approximated with hollow cylinders. All other collateral tissues 
were formed by differencing off these key anatomical structures from a tissue block. These collateral 
tissues were treated as a generic tissue volume encompassing all of the surrounding viscera. Of the 
regions formed by this operation, all internally confined regions were designated as blood, and all 
external regions were treated as a generic collateral tissue volume (a mixture of adipose, connective, 
and lung tissues). 
The structures not included in this model were the left atrial appendage and the left lateral 
ridge located outside of the appendage. The appendage is a blind pouch on the anterior side of the 
heart which contributes greatly to thrombus risk, but in general plays a lesser role in ablative 
treatment of left atrial arrhythmias. Additionally, the anatomy of this appendage is highly variable and 
irregularly shaped [90]. The left lateral ridge marks the join between the appendage and the rest of 
the atrial body and is made of a thickened mass of muscle and connective tissues. This ridge is 
important procedurally, but it is more critical to catheter navigation and tip/tissue contact rather than 
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catheter tip ablation performance. Exclusion of these structures aided in reducing geometric 
complexity and allowed for a central plane of symmetry to be implemented. 
Additionally, the major axes of the anatomical model were shifted to align with a more 
standard Cartesian system, with the plane used in 4 chamber echocardiography imaging used as the 
basis for the anterior XY plane, and the left-right PV bisecting line serving as the basis for the YZ plane. 
This configuration is illustrated in the figure below [Figure 15]. 
 
Figure 15. Planes Used to Map Left Atrial Geometry from Anatomical Positioning to a Standard XYZ 
Configuration. 
4.3.3 Left Atrial + Adjacent Structure Dimensions 
 Dimensions were gleaned from studies on both living and deceased hearts. No single 
anatomic study captured all the dimensions needed for constructing the left atrial model. Due to the 
multiple sources consulted and high degree of anthropomorphic variability—as influenced by size, age, 
sex, concurrent pathology, and more—higher priority was given to cardiac dimensions from subjects 
over the age of 40 with diagnosed AF and moderate atrial enlargement. When possible, they were a 
compromise between the high end of female and the low end of male dimensional ranges. 
Dimensions for modeling are summarized in the following tables [Table 1, 2, 3]. 
  
Y 
X 
Z 
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Table 1. Dimensions for Left Atrial Anatomy.  
4CV = 4 chamber view, from echocardiographic studies. Unless otherwise indicated, values presented 
as means (range).  
Structure Literature Values Sources Value Used in Model 
LA General Dimensions 
LA Major Axis (4CV) 
 
44.0 ± 6.5 [mm] [91] 
 
56\m 
51 ± 10 [mm] 
 
[92] 
Longitudinal diameter 64.2 ± 7.8 [mm] 
 
[66] 
LA Minor Axis (4CV) 35 ± 8 [mm] 
 
[92] 37 mm 
Anterior-posterior diameter 33.1± 6.3 mm [66] 33 mm 
Atrial Wall Thickness 
Average 0.6 – 1.0 [mm]  
(0.5 – 5.0 [mm]) 
 
[79] 3.0 mm all around 
Roof 5.0 ± 1.5 mm 
 
[92] 
Anterior Wall 
 
3.2 ± 1.6 [mm] [92] 
2.09 ± 0.89 [mm] 
 
[80] 
Posterior Wall 1.33 ± 1.46 [mm] [80] 
 
Table 2. Dimensions for Collateral Structures Near the Left Atrium. 
Structure Literature Values Sources Value Used in Model 
Aorta 
Diameter 
    Descending  
    Sino-tubular junction 
 
2.59 cm 
3.28 cm 
[93] 3 cm 
Wall Thickness 1.60 ± 0.22 mm [94] 1.5 mm 
Esophagus 
Diameter 15-18.5 mm [95] 15 mm 
Wall Thickness 2.11 – 4.70 mm [95] 3 mm 
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Table 3. Dimensions of the Pulmonary Veins and Mitral Annulus. 
Structure Literature Values Sources Value Used 
in Model 
Pulmonary Veins 
Wall thickness, 
Venoatrial junction 
Carina ~ 3.2 mm 
Veno-atrial junction 1-1.5 mm 
 
[66] 3.0 mm 
LSPV Diameter 
 
19.3 ±2.5 [mm] [68] 
 
Outer 
Diameter, 
all PVs: 
15 mm 
 
Inner 
Diameter, 
all PVs: 
13 mm 
Major: 20.6 ± 3.4 [mm] 
Minor: 13.3 ± 3.0 [mm] 
[96] 
18.4 ± 2.1 [mm] 
 
[97] 
LIPV Diameter 
 
 
17.3 ± 1.5 [mm] [68] 
Major: 
18.3 ± 3 
Minor: 
12.1 ± 2.8 
[96] 
 
  
RSPV Diameter 
 
Major: 
22.3 ± 4.4 
Minor: 
16.6 ± 3.9 [mm] 
[72]  
  
RIPV Diameter 
 
Major: 
20.9 ± 4.7 
Minor: 
16.3 ± 3.7 [mm] 
[72]  
  
Inter-orifice 
Separation 
Left 
1.2 - 3.4 cm 
Right 
0.4 – 3 cm 
[98] 8 mm 
Mitral Annulus 
Major diameter M, End Systole: 3.44 cm 
M, End Diastole: 3.15 cm 
F, End Systole: 3.11 cm 
F, End Diastole: 2.83 cm  
 
[99] Major 
diameter: 3 
cm 
Minor 
diameter: 2 
cm Transverse 
Diameter, 
Parasternal View 
 
2.1 ± 0.4 cm [100] 
Horizontal 
Diameter, 
Parasternal View 
2.3 ± 0.6 cm [100] 
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4.3.4 Constructing the Full Left Atrial Model 
The left atrium was modeled as a revolved base, with an inner diameter of 15 mm 
(corresponding with ascending aorta outer diameter, and an outer diameter of 60 mm. This formed a 
wedge shape with an arc to arc separation of 45 mm. Successive cuts were made to roughly ‘sculpt’ 
the morphology of the left atrium. Edges were further shaved off with chamfers, before applying fillets 
with wide diameters (~5-10 mm) to round off the edges of the model. The LA body was then shelled to 
an inner wall thickness of 3 mm all around. This dimension is an average value of the reported ranges 
of wall thicknesses for the left atrium. As described in Chapter 2, the thickness of the wall varies 
regionally, with significant impact on procedural success in clinic. For the purposes of evaluating 
simple transmurality, the 3 mm thickness is adequate. If further studies are performed with a greater 
emphasis on anatomical realism and/or collateral damage concerns, then it will be important to align 
the wall thicknesses with in vivo variations. 
To model the mitral valve, an elliptical cut with a major diameter of 3 cm and a minor 
diameter of 2 cm was projected through the inferior aspect of the LA anterior wall. Next, two circular 
extruded cuts with a diameter of 13 mm were made through the superior face of the posterior wall at 
the approximate site of the veno-atrial junction, then mirrored across the top plane. The vertical 
positioning of these pulmonary veins were adjusted so that the orifices had an intermediary distance 
of 8 mm. An additional 15 mm circle was centered at each circular cut, and then the two profiles were 
swept along a curved 3D path away from the LA body to form hollow pulmonary veins.  
The final model had an abundance of faces, which hindered successful meshing; therefore, 
several preprocessing operations were performed to prepare the model for import into COMSOL. 
These included merging adjacent faces on the exterior and interior of the model and eliminating any 
aspects that might be considered a “sharp” face or feature (i.e. anything with an angle << 90 
degrees). For dimensioned drawings of the left atrial assembly, see [Figure 16; Appendix E].  
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Additional domains were formed in SolidWorks® by closing the openings of the LA with planar 
surfaces, overlaying the entire geometry with a solid block, then intersecting the two geometries. This 
Figure 16. Side View of Atrial Model.  
A) Broken Out Section depicting inter-orifice distance and pulmonary vein dimensions. B) Left atrial 
assembly, including esophagus (blue) and aorta (green). 
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method was used to generate the blood volume, as well as the collateral tissue volumes. Also, hollow 
pipes representing the aorta (OD=30 mm / ID=27 mm) and esophagus (OD=15 mm / ID=9 mm) were 
modeled, then differenced off from collateral tissue block. Each part was then positioned using mating 
tools to form an assembly.  
 Due to the symmetry of the geometry, the assembly was bisected axially to enhance 
computational efficiency. This assembly was then exported as a Parasolid binary (.x_b) filetype, which 
in this particular application performed better than the STL and native SolidWorks ® filetypes when 
importing geometry into COMSOL® Multiphysics. The following image depicts the labeled finalized 
geometry of the LA model space [Figure 17]. Additional views of this geometry can be found in 
[Appendix E, Appendix G]. 
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Figure 17. Left Atrial Assembly in COMSOL Multiphysics. 
Left atrium highlighted in blue.  
Catheter Tip 
Electrode 
Esophagus 
Left Atrium 
Ascending 
Aorta 
Mitral Valve 
Annulus 
Collateral Tissues Pulmonary Vein 
Study Region 
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While not visible in the side views, the mitral valve annulus was capped by a planar surface which 
allowed for boundary condition assignment without having to model an interfacing ventricular 
geometry.  
 Physical Model Definition 
The finite element analysis software COMSOL Multiphysics® was used to build the ablation 
simulations using the geometries. The electric currents, laminar flow, and bioheat transfer physics 
modules were coupled by non-isothermal flow and electromagnetic heat source multiphysics.  
4.4.1 Assumptions  
Several key assumptions were made when creating this ablation model: 
1) The materials had homogenous properties. 
2) Electrical contact between electrode and tissue was assumed to be perfect [41].  
3) Since the wavelength of the RF energy is 500 kHz, all heating in the problem occurred 
through resistive heating, therefore a quasi-static approximation was applied.  
4) Constant RMS voltage was equivalent to the average voltage output from the RF wave.  
5) Flow in the left atrium was approximated by laminar fluid flow due to the predominantly 
passive flow/reservoir function of the left atrium. 
6) Simulation of non-Newtonian blood flow was not critical for the purposes of left atrial ablation. 
7) The pulmonary veins were approximately equidistant and had the same dimensions. 
8) All “collateral” tissues could be approximated by general muscle properties. 
 
4.4.2 Boundary Conditions 
 The following table summarizes the pertinent boundary conditions and initial values for the 
laminar flow, electric currents, and bioheat transfer physics, as well as the domains to which they were 
assigned [Table 4].  
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Table 4. Overview of Boundary Conditions + Initial Values of the Left Atrial Ablation Model 
Physics Domains/Boundaries Initial Values Boundary Conditions 
Laminar Flow Blood Saline Ports 
P0 = 0 [Pa] 
u0 = 0 [m/s] 
 
Normal inflow velocity 
Outlet zero pressure: p = 0 Pa 
No slip wall condition 
 
Electric 
Currents 
Electrode 
Blood 
Myocardium 
Collateral tissues 
V = 0 [V] 
E = 0 [V/m] 
 
Ground, posterior and inferior 
walls: 0 V 
Electrical potential on electrode: 
50 V 
Electrical insulation on proximal tip 
end 
 
Bioheat 
Transfer 
 
Blood 
Myocardium 
Collateral tissues 
Saline 
 
T = 37 [⁰C] Arterial Blood Temperature: 37 ⁰C Saline Temperature: 20 ⁰C 
 
 The posterior and inferior walls of the tissue block were designated as ground (V = 0 V) to 
approximate the dispersive electrode, while an electrical potential was applied to the catheter tip 
surface. The energy output had a frequency of 500 kHz. Electrical insulation was assigned the 
irrigation port and proximal tip surfaces. For the thermal model, all domains were set to baseline 
physiologic temperature of 37 ⁰C. The boundary electrothermal heat source was coupled. To simulate 
cooling by the saline irrigant, a temperature boundary condition of 20 ⁰C was applied to all 6 irrigation 
ports on the catheter tip. Additionally, a temperature condition of 37 ⁰C was placed on the pulmonary 
vein inlets, to simulate fresh blood flow. 
 While the geometry included portions of the aortal wall, the heat gradient was found to be 
essentially negligible in this portion of the atrium; thus, the boundary condition of lumen surface of the 
aorta was set to a constant 37 °C. Mass transport modeling was limited to atrial blood flow and saline 
irrigation. Saline flowed laminarly from the six irrigation ports at either 17 mL/min or 30 mL/min, 
which corresponded with a velocity of 0.06 m/s or 0.14 m/s, respectively. Based on Doppler 
echocardiography, an inflow velocity of 0.2 m/s was set on the pulmonary vein entrances. For this 
model, the ventricles and ventricular cavity were not simulated, but a zero-gage-pressure no back-flow 
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outlet condition was applied to the mitral valve opening to simulate the transit of oxygenated blood 
from the left atrium to the ventricle. The development of flow was then solved for by COMSOL. 
Additionally, a Point Pressure Initial Condition which assigned a 0 Pa gage pressure was applied to a 
point on the mitral valve opening. While this seemed redundant given the mitral valve boundary 
condition, the “priming” of the solution space for the Navier-Stokes was necessary to converge on a 
solution.  
 
Figure 18. Boundary Conditions of Full Left Atrial Model Space. 
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 Material Properties 
 The table below summarizes the material properties referenced, separated by material 
domains. For images depicting each material domain, see [Appendix G].  
Table 5. Thermal and Electrical Material Properties, Temperature Independent.  
* indicates properties with a potential temperature-dependent variant. 
Parameter Value Units Source 
Myocardium 
Density 1060 kg/m3 [45] 
Thermal conductivity 0.531 W/(m·K) [101] 
Electrical conductivity* 0.6 S/m [102] 
Relative permittivity 3260  [103] 
Specific heat 3111  J/(kg·K) [45] 
Perfusion 0.0064 1/s [104] 
Blood 
Density* 1060  [45] 
Thermal conductivity 0.5 [W/m*K] W/(m·K) [101] 
Electrical conductivity* 0.667 [S/m]  
[102 
[45] 
Relative permittivity 1800  [105] 
Specific heat 3900  J/(g·K) [104] 
Dynamic viscosity 0.00345 Pa s [107] 
Generic Muscle 
Density 1060  kg/m3 [108] 
Thermal conductivity 0.642 W/(m·K) [104] 
Electrical conductivity* 0.446 S/m 
[102] 
[103] 
Relative Permittivity 3650  
[105] 
[103] 
Specific heat 3.72 J/(g·K) [101] 
Perfusion 0.0015  1/s [104] 
 
While not studied fully in this model, the electrical conductivity of tissues is strongly influenced by 
temperature, and could be implemented via a piecewise function, interpolation of tabulated values, or 
an analytical function tied to the property variable in COMSOL Multiphysics®. 
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 Mesh Development 
 Several meshing strategies were implemented to improve element quality while minimizing 
the degrees of freedom needed to generate stable solutions. These included geometric subdivisions, 
mesh element sizing convergence, biasing evaluations, and element quality assessment.   
4.6.1 Geometry Subdivisions 
 The geometry of the 3D models was divided using a spherical subdomain centered on the 
catheter to provide more control on mesh propagation and concentrate mesh biasing. To select the 
optimal diameter for this spherical subdivision—hence-forth referred to as the region of interest (ROI)—
convergence testing was performed on the small ablation model. A 50 V constant potential was 
applied to the electrode for a treatment time of 60 seconds. Three-dimensional isotherms were 
plotted to highlight the transition zone from 37.1 ⁰C to the basal body temperature of 37 ⁰C, as 
depicted in [Figure 19].  
 
Figure 19. 37 ⁰C and 37.1 ⁰C Isotherms to Determine Ideal Study Region Diameter.  
Constant voltage ablation for 60 s, no blood flow or saline irrigation. 
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 For the simplified 3D model, the initial 4x4 cm tissue/blood column proved to be an 
insufficiently large study space; therefore, iterative simulations were performed with progressively 
larger study regions until there were no boundary effects. Boundary effects were identified by 
observed distortion and flattening of the 37.1 ⁰C isotherm parallel to the adjacent tissue/blood 
domain boundaries. This assessment was done with no blood flow to provide the “worst case” (i.e. 
largest extent) scenario for the subdivision. The ultimate spherical radius was set at 10% larger than 
the diameter of the 37.1 ⁰C isotherm, which corresponded with a radius of 1.4 cm. This diameter was 
then applied to both 3D models. 
4.6.2 Study Region Convergence 
 The use of the spherical subdivision helped to reduce solution times and degrees of freedom. 
Areas of the simulation geometry outside of the spherical domain were set to large element sizes (max 
15 mm), with up to 1.25x adjacent element size propagation. More gradual mesh biasing was applied 
in the ROI for blood and tissue, at a rate of 1.15x per layer of elements.   
Figure 20. Element Size Convergence Studies.  
Progressively finer meshes evaluated to determine minimum element sizing for optimum computational 
efficiency. Convergence performed on spherical study region in small model. Converged dimensions 
from small model applied to study region in full atrial model. 
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The governing rules for element sizing were that max ROI was less than or equal to the 
minimum ROI dimension, and that the max ROI dimension served as the minimum dimension of the 
coarsely meshed tissue and blood regions. Dimensions between 0.01 and 100 mm were tested. The 
dimension combinations tested are depicted on the graph below [Figure 21].  
  
Figure 21. Dimension Combinations from Element Sizing Convergence Studies.  
Axes values on logarithmic scale. Cutoff represents combinations outside of the search space (i.e. Min 
> Max). 
 
To evaluate the impact of mesh size on solution stability, domain and point probes were 
defined to sample maximum temperatures in the blood and tissue domains, as well as tissue 
temperature as a function of distance from the tissue/electrode interface. Temperature was tracked 
from the interface temperature to 6 mm below, in steps of 1 mm. In addition to element size 
combinations, degrees of freedom were tracked for each simulation.  
The percent difference in 60 second temperature values was calculated by dividing the 
difference in temperatures by the temperature associated with the lower degree of freedom 
simulation, as shown by the following equation.  
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Meshes were considered converged when there was <0.25% deviation in any of the measured 
temperature values for the sampled tissue depths. Degrees of freedom were plotted against 60 
second temperature deviations between sampled values to monitor for convergence [Figure 22]. 
 
Figure 22. Mesh Convergence Plot: % Difference in Temperature at Tissue Depths of 3- and 5-mm vs 
the Degrees of Freedom in the Solution.  
The parallel bars on the graph represent the ±0.25% bounds for convergence. The dashed lines 
highlight overall funneling trend of datapoints with an increase of degrees of freedom.  
  
 The plot suggests that the deviation in temperature response due to degree of freedom 
roughly converged within ± 1 % above 121,000. While it is possible that a finer mesh could reach a 
smoother convergence, run times (>6 hours) and RAM limits (16 GB) made models with mesh 
elements smaller than 0.01 mm impractical to run. Furthermore, since convergence was done on the 
simplified 3D model, the increased size and complexity of the full atrial model would make the use of 
this element size even more unfeasible. Therefore, to narrow down potential size combinations, a filter 
on minimum tissue element quality, as measured by skewness, was set at 0.20 or higher. The set of 
dimensions associated with a DOF greater than 121,000 that produced an acceptable element quality 
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was a max length of 1 mm and a min length of 0.05 mm. Mesh configurations for all domains are 
depicted in [Figures 23 and 24].  
 
Figure 23. Mesh Tissue Domains (Blue) and Blood Domain (Grey) in Full Model,  
General tissue domain has max element size: 7.26; minimum element size: 15; Curvature Factor 0.6; 
Resolution of narrow regions: 0.5; Maximum element growth rate: 1.25. Max element size: 3.5 mm; 
min element size: 0.05; Curvature Factor: 0.5; Resolution of Narrow Regions: 0.7; Maximum element 
growth rate: 1.25. 
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Figure 24. Tetrahedral Mesh on Tissue (Blue) and Blood (Grey) Spherical Study Regions.  
For tissue study region (blue), max element size: 15; min element size: 0.05; Curvature 
factor: 0.75; Resolution of narrow regions: 0.75; max element growth rate: 1.15. For blood 
study region (grey half circle), max element size: 15; min element size: 0.05; Curvature 
factor: 0.75; Resolution of narrow regions: 0.75; Max element growth rate: 1.15. 
 
 COMSOL Multiphysics® balances model physics and the user’s mesh parameter definitions 
when generating meshes for a domain. Interestingly, while both tissue and blood ROI’s were assigned 
the same element size growth rate (1.15), there was much a larger and more drastic growth of 
element sizes on the blood region compared with the tissue ROI, which barely changed from the finest 
region (i.e. near the blood/tissue interface) to the edges of the ROI adjacent to the esophagus. 
 The finalized mesh of all regions resulted in 965,160 degrees of freedom (DOF) when solving 
for the perpendicularly-oriented electrode, with temperature independent properties and saline/blood 
flow inclusion. 
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4.6.3 Element Quality Observations 
Distribution of element quality was also analyzed graphically, with a color scale representing 
average element quality plotted per element. Element quality is important to the accuracy of the 
solution and is tied to the underlying theory of finite element analysis (i.e. Galerkin’s Approximation 
Method). Briefly, the problem is modeled mathematically as a second order integral which includes an 
approximate solution and test functions governed by the physical conditions. Defining the problem in 
this way, after some derivation, leads to an approximately linear form of the solution, where the 
resultant “forces” are a result of the “displacements” multiplied by the “stiffness matrix. Solution of 
the problem requires integration of these functions at each node to form the stiffness matrix for a 
single element, while intermediate behavior is extrapolated through the element. Therefore, excessive 
element distortion leads to issues in the formation of the stiffness matrices for each element, which in 
turn leads to lower solution accuracy.  
Overall element quality for the left atrial assembly was 0.6430. Elements with higher element 
quality were labeled in green, and elements with lower element quality were labeled in red. Based on 
the color distribution within the model, average element quality was 0.5 or higher within the study 
region, as shown in [Figure 25]. 
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Figure 25. Element Quality Plot, Medial View of Bisected Left Atrial Anatomy. 
Structures visible include the aorta (left), left atrium (center), esophagus (right), ROI, blood, and the 
generic surrounding tissue volume. Element quality was plotted on a rainbow color scale, with better 
quality elements in red and lower quality elements in blue. 
 
Areas of particularly low quality were the external faces of the aorta and esophagus. This was due to 
the discrepancy between external element faces, and the interstitial element faces, where the wall 
thickness dimension was much smaller than the external surface element dimensions, as shown in 
the following image [Figure 26].  
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Figure 26. Element Quality Plots of Aorta, Region of Interest, and Esophagus.  
Mesh elements shaded by quality—as determined by skewness, with higher element quality in green 
and lower element quality in red. Lateral view of simulation space. Tissue, atrium, and blood hidden to 
highlight the aorta (right), region of interest (sphere), and the esophagus (left). 
 
As only 1 layer of tetrahedral elements were used to construct the esophageal and aortic 
meshes, this resulted in flattened tetrahedrons, like the ones modeled below [Figure 27].  
 
These structures were not critical to the objectives of this model but could be rectified with smaller 
element sizing if tracking the heating and damage of the aorta or esophagus was a priority. 
 Time Discretization 
By default, time stepping values in COMSOL Multiphysics ® are governed by a Backward 
Differentiation Formula (BDF) solver, which uses a range of time steps based on the dynamics of the 
problem. For each time step, the largest possible increment was determined by the solver. A sample 
Figure 27. Equilateral Tetrahedral Element (Left) Versus Flattened 
Tetrahedral Element (Right). 
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plot of the time-dependent solver timestep convergence is included below [Figure 28]. 
 
Figure 28. Convergence Plot of Time Dependent Solver.  
Step size selected by Backward Differentiation Formula. Time step size determined based on time-
dependent dynamics of the simulation. Maximum time step: 1/1 = 1 second; minimum time step: 
1/103 = 0.001 second. 
 
During simulations of the small and full models, time steps tended to fall between 0.001 and 1 
seconds. To limit the solution space—which in some cases limited the solution time—the lower bound 
was set to 0.001 s. Additionally, a stricter BDF condition was applied such that the solver had to take 
at least one time step on the sampling interval of 0.1 s (from the solution interval 0:0.1:60 seconds).  
 FEM Analysis Steps 
The coupled electrical-thermal-mass transport problem was solved using two study 
formulations. The study steps defined which equation form and which solver was used to derive the 
solution.  
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4.8.1 Step 1: Stationary Study  
 While the flow through the atrium is not perfectly laminar, it is sufficiently non-turbulent and 
passive that it can be approximated with a laminar flow. With consideration for computational 
limitations, the flow solution was generated using a stationary solution method, then used to 
propagate heat in later solution steps. Flow was solved for directly using the PARADISO stationary 
solver. 
4.8.2 Step 2: Frequency Transient Study 
 The frequency transient solution step was used to solve for the electric field due to the 
ablation process. Heat transfer was also solved for during this step, integrating the flow fields of blood 
with the electrical heating of the electrode and perfusion of the cardiac tissue. This was computed 
with an iterative Geometric Multigrid solver.  
 Validation Case Study 
 To validate the model, the lesion dimensions and temperature profiles from the simulation 
were compared with in-vivo lesion studies using the Biosense Webster Thermocool RF catheter. In the 
validation case study, lesion data was generated using power-controlled 30W ablations for 60s in 
anesthetized adult pigs. The Thermocool catheter was irrigated with 17 mL/min of heparinized saline 
(1000 U/L). Parameters of the ablations are summarized in the table below [Table 6].  
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Table 6. Biosense Webster Thermocool Ablation Procedural Parameters for In-Vivo 30W/60 sec 
Ablations in Porcine Models. From Moreno et al 2014 [109] 
 
Input Parameter Units Value 
Voltage [V] V 48.3 ± 2.6 
Current [mA] mA 619.4 ± 11.9 
Power [W] W 29.5 ± 0.4 
Perpendicular Ablation Results   
Max Diameter mm 10.3 ± 1.5 
Depth Max Diameter mm 3.6 ± 0.6 
Depth mm 9.3 ± 1.4 
Volume mm3 555 ± 151 
Tangential Ablation Results   
Max Diameter mm 10.1 ± 1.6 
Depth Max Diameter mm 3.0 ± 0.8 
Depth mm 8.1 ± 1.8 
Volume mm3 530 ± 128 
  
Power output was approximated by a voltage of 50 V to the electrode surface using the terminal 
boundary condition. The terminal is a boundary condition in the AC/DC module of COMSOL 
Multiphysics® that allows the user to model voltage, current, and power sources. It can be used to 
model such things as current- or voltage-limited power supplies, or as a means of interfacing a circuit 
(e.g. one built in MatLab®) to the Multiphysics model. In addition, a saline irrigation rate of 17 mL/min 
applied across the 6 ports (equivalent to a normal velocity of 0.06 m/s at each port). Ablations were 
then performed for 60 seconds, and max depth and diameters were recorded for the perpendicular 
and tangential electrode orientations. 
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 Damage Evaluation Methods 
As described in Chapter 3, there are two methods of damage evaluation available in the 
COMSOL Bioheat module: (1) temperature threshold, and (2) Arrhenius damage integral based. In 
both modalities, damage is computed as a fraction of necrotic tissue and is represented by the symbol 
Ω. Damage values run from 0 to 1, where 1 represents total, irreversible damage. Both damage 
criteria were evaluated in a 2D ablation model to select which would be used for lesion measurement 
in further studies. When compared against the commonly-used 50 ⁰C isotherm—the temperature of 
tissue protein coagulation—the Arrhenius damage formulation for myocardium estimated a smaller 
lesion than the temperature-based method, as shown on the following page [Figure 29].  
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The lesion defined by the temperature-threshold criteria more closely matched the experimental 
validation case dimensions. Damage evolution as calculated by the COMSOL solver is included as a 
Figure 29. Comparison of Damage Criteria for Lesion Measurement in Ablation Studies.  
Damage determined by A) standard 50 °C isotherm, B) temperature threshold-based damage, or  
C) Arrhenius damage integral. Parameters for the Arrhenius damage integral tailored for 
myocardium: A = 3.0 E 3 [Hz], Ea = 1.62 E 5 [J/mol]). 
A 
B 
C 
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step during segregated solution of the bioheat equation; this leads to longer solution times. Since the 
temperature-threshold lesion was essentially the same as the 50 °C isotherm for this ablation case, 
both COMSOL-based evaluations of damage for lesions were not considered in further studies.  
Should use of the Arrhenius damage integral be applied in later versions of this testbed, 
optimal values for activation energy would need to be determined. Cursory parametric studies on the 
activation energy suggested that the myocardial activation energy would need to be lower to achieve 
similar results to the validation case study [Appendix J]. 
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Chapter 5 
RESULTS 
 Multiphysics Verification with Simplified Models 
 Perpendicular and tangential ablations were performed in a 2D and simplified 3D model to 
verify the researched physics, materials properties, and boundary conditions. Morphology, 
temperature distributions, and lesion size were compared against similar ablation parameters as an in 
vivo experimental study [109]. Once successful physics implementation could be achieved, the 
bioheat model could then be applied in the full atrial model. Overall, the morphology of the lesions 
produced in these simplified models matched typical ellipsoid morphology for monopolar RF ablations 
[Figure31, Figure32].  
Interestingly, the 3D models reached higher temperatures near the electrode-tissue interface yet 
produced relatively equivalent lesion depths (6.8 vs 6.9 mm and 7.6 vs 7.1 mm for perpendicular and 
tangential, respectively). Lesion dimensions from these initial as summarize and compared against 
the Moreno et al [109] lesion study in the table below [Table 7]. 
Table 7. Lesion Dimensions from Verification Studies in 2D and Simple 3D Ablation Models. 
 Max Depth % Difference Max 
Diameter 
% Difference 
Perpendicular Ablations 
Moreno et al 9.3 ± 1.4 --- 10.3 ± 1.5 --- 
2D Model 6.8 -26.9% 9.4 -8.7% 
Simple 3D Model 6.9 -25.8% 11.4 +10.7% 
Tangential Ablations 
Moreno et al 8.1±1.8 --- 10.1±1.6 --- 
2D Model 7.6 -6.2% 10.7 +5.9% 
Simple 3D Model 7.1 -12.3% 12.5 +23.8% 
 
Percent difference in means ranged from 5.9 – 26.9%; however, apart from the perpendicular ablation 
max depths, all measured lesion dimensions fell within the spread the experimental values.  
Additional simulations examined the effect of blood flow, saline irrigation, and temperature-
dependent properties on ablation performance. Images and more in-depth description of these 
aspects are located in [Appendix H]. 
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Figure 30. Temperature Distribution and Lesion Isotherms of Perpendicular Electrode Orientation 
Ablations in the 2D (Top) and Simplified 3D (Bottom) Models 
Images aligned to match length scales.  
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Figure 31. Temperature Distribution and Lesion Isotherms After 60 Second Ablation With a Tangentially 
Oriented Electrode for the 2D (Top) and Simplified 3D (Bottom) Preliminary Simulations. 
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 Initial Simulations + Modifications to the Full Atrial Model 
Aortal blood flow was originally included in the simulations of the left atrial model; however, 
based on the chosen location of the ablation site in this particular simulation, the aorta was far 
enough away and the blood velocity high enough that the thermal effect could be approximated by a 
37 °C boundary condition. 
 
Figure 32. Temperature Plot, Medial View of Left Atrium Assembly. 
 
 While the focus of this geometry was in providing locations around the PV ostium for ablation, 
if other treatments are trialed and/or the geometry is modified, the aortal flow might become a 
significant heat sink. Thus, this 37 °C boundary condition would need to be re-evaluated on a case-by-
case basis. 
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 Full Atrial Model vs Validation Case Lesion Comparison 
 Ablations performed in the left atrial model with a constant voltage of 50 V, saline irrigation of 
17 mL/min, and cooling due to blood flow and tissue perfusion resulted in ellipsoid lesions with 
surface diameters slightly larger than the electrode tip [Figure 33].  
 
Figure 33. Lesion Morphology of 50 V, 60 s Ablation, Perpendicular Electrode Orientation.  
The 50 °C isotherm is highlighted in cyan. Color gradient indicates temperature distributions 
below 50 °C, with lighter pink indicating higher temperatures and darker purple indicating 
lower temperatures (~20 °C). 
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Figure 34. Temperature Distribution Following a 50 V, 60 Second Ablation, With Electrode Tip Oriented 
Perpendicularly to the Myocardial Surface. 
 
Maximum lesion depth for this ablation was 0.8 mm, and maximum lesion diameter was 3.4 mm, as is 
summarized in the following table [Table 8]. Compared with the validation case, this represented a 
91.3 and 70.0% difference, respectively.  
 The tangentially oriented electrode ablation produced lesion values much closer to those 
found in the validation study, as shown in the following image [Figure 35]. The max depth and max 
diameter were 5.8 and 10.9 mm respectively, which corresponded with a percent difference of -28.4% 
and 7.9% from the reported values by Moreno et al 2014 [109]. 
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Figure 35. Temperature Distribution Following a 50 V, 60 Second Ablation, With Electrode Tip Oriented 
Tangentially to the Myocardial Surface. 
 
Table 8. Comparison of Lesion Dimensions from Left Atrial Simulations and Experimental Lesion 
Studies.  
 Max Depth 
[mm] 
% 
Difference 
Max Diameter 
[mm] 
% 
Difference 
Perpendicular Ablations 
Moreno et al 9.3 ± 1.4 --- 10.3 ± 1.5 --- 
3D Left Atrial Model 0.8 91.3% 3.4 70.0% 
Tangential Ablations 
Moreno et al 8.1±1.8 --- 10.1±1.6 --- 
3D Left Atrial Model 5.8 -28.4% 10.9 7.9% 
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 Diagnostics to Determine Root Cause of Perpendicular Lesion Size Discrepancy 
5.4.1 Flow Velocity Distribution in the Full Atrial Model 
In the simple case of the rectangular model, though, flow path and velocity did not change 
substantially within the simulated blood volume. Outflow in this case was normal to the outlet 
boundary and remained at the same inlet velocity (i.e. 0.13 m/s). The flow path in the left atrial model, 
on the other hand, was more influenced by structure-fluid relations. Streamline plots indicated that 
flow across the ablation site was approximately parallel to the tissue surface [Figure 36].  
 
In the left atrial model, initial blood velocity was specified by a normal inflow condition at the PV 
inlets, commensurate with the pulmonary venous velocities measured by Doppler echocardiography in 
vivo. At the mitral valve outlet boundary, a 0 Pa gage pressure was applied, and flow between these 
points was solved for with a steady state laminar flow formulation. A plot of the flow velocity 
distribution is depicted in the following image [Figure 37].  
 
Figure 36. Streamlines of Blood Flow for Non-Irrigated (Left) and Saline-Irrigated (Right) Simulations in 
the Left Atrial Model. 
Blood flow streamlines in red, saline flow streamlines in blue. 
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Figure 37. Blood Velocity Magnitude in the Left Atrial Model, Pulmonary Vein Inflow Velocity of 0.15 
m/s. Transmitral velocity ~0.3 m/s, overall left atrial velocity between 0.05 and 0.10 m/s. 
 
The resulting blood velocity distribution in the left atrial model varied with location, as was expected. 
Velocity distribution in the left atrial model remained low (<0.1 m/s) in the upper atrium, but quickly 
climbed to 0.15 m/s in the vestibular region, reaching 0.35 m/s at the center of the mitral valve 
annulus.  
Table 9. Comparison of Blood Velocities in Doppler Echocardiography Study of AF Patients [89] vs the 
Left Atrial Model. 
 
Location Literature [m/s] Model [m/s] 
Domain Average 0.13 +/- 0.02 0.042 
Transmitral (Luminal) 0.30 +/- 0.10 0.141 
Ablation Site N/A 0.017 
 
 When compared against flow studies created by MRI segmentation and CFD simulation, 
velocities of flow were similar or small in magnitude than in patients in AF, as depicted in [Figure 38].  
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Figure 38. Flow Through the Left Atrium for Patients in AF and Sinus Rhythm. 
Image credit: Dillon-Murphy et al 2018 [110]. Published under Creative Commons Attribution Licences 
4.0 (https://creativecommons.org/licenses/by/4.0). 
 
Nevertheless, the flow patterns of simple LA geometry differed greatly from the segmented model. 
Significant vortices in the atrial vestibule in the Dillon-Murphy et al study were only observed during 
peak flow in sinus rhythm. Critically though, flow near the ablation site was approximately parallel with 
the walls but with much lower velocity (~0.017 m/s) than in the simple preliminary models where flow 
was defined directly and had negligible fluid-structure interaction. 
 Electric Field in the Full Atrial Model 
 Interestingly, the electrical distribution in the full left atrial model favored higher current 
densities in the blood rather than the tissue, despite the ground (V = 0 V) boundary condition being in 
closer proximity to the tissue [Figure 39].  
 
68 
 
Figure 39. Electric Field with Overlaid Current Density Vector Field. 
 
The magnitude of the current density vector was 2x that of the directed toward the tissue. Considering 
that all other boundaries were treated as electrically insulative, these results were peculiar and may 
warrant further investigation into material properties or boundary conditions.  
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 Contact Area Investigation: Removal of Tissue Tenting 
 To investigate the impace of the reduced contact area due to the tissue tenting depression, 
the conical indent was removed and the simulation run with complete tip contact, as depicted in 
[Figure 40]. The results suggested that increased contact area did not result in deeper lesions. 
 
Figure 40. Temperature Distributions in Full Atrial Model Following a 50 V, 60 Second Ablation with 
Tissue Tenting (Top) and Complete Insertion Contact (Bottom). 
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Chapter 6 
DISCUSSION 
 A three-dimensional multi-physics model of the left atrium was developed to provide a more 
anatomically relevant testing environment for in silico evaluation of ablation catheter electrode tip 
designs. To achieve this, an anatomical assembly was developed in computer aided drafting software 
and transferred to COMSOL Multiphysics ®. The physical model was generated using the electrical, 
thermal, and mass transport physics interfaces. Through these interfaces, the coupled Joule heating, 
Pennes’ bioheat transfer, and incompressible Navier-Stokes flow equations were solved using finite 
element methods. Ablation lesions for a gold-standard RF ablation device (Biosense Webster Navistar 
Thermocool®) were generated during 60s, 50 V constant voltage ablations and compared with in vivo 
lesion characterization studies performed with this device.  
 Assessment of Multiphysics and Catheter Design Aspects in 2D and 3D Models 
Physics and material properties were assessed in a simplified 3D ablation case, as is commonly 
reported in literature. Mean lesion dimensions in this model were between 5.9 – 26.9% different from 
the reported values of the Moreno et al 2014 in vivo lesion study. When compared with the range of 
reported values though, most of the measurements fell within the range indicated by the means ± 
standard errors. With reasonably similar result, other procedural and design aspects were evaluated. 
These included the effect of blood flow, tip saline irrigation, and temperature-dependent properties on 
lesion production and morphology. The cooling effect of blood flow was substantial and necessary to 
achieve the classic ellipsoid lesion morphology. Saline irrigation reduced interface temperature and 
damage, although there was no discernible change in lesion dimensions. Finally, temperature-
dependent properties formed smaller lesions—as expected—due to thermally mediated reduction of 
electrical conductivity. 
 The Left Atrial Anatomical Model 
  Desirability of the left atrial CAD model was a balance of anatomical fidelity versus 
computational efficiency. Aspects such as model symmetry and importability into COMSOL 
Multiphysics with minimal errors made for easier mesh generation and physics modeling. One of the 
main advantages of the developed model was the relative ease of customizability. New tissue domains 
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and catheter tip designs could be easily edited, added, positioned, and rebuilt within the assembly. 
Furthermore, exporting domains as an aggregated assembly cut down on lengthy repositioning and 
modification times in COMSOL’s native CAD environment. 
 While modeling the geometry rather than producing it through image segmentation made for 
easier construction and catheter tip positioning, many anatomical aspects were simplified extensively 
or not included. As detailed in Chapter 2, the left atrial myocardial wall thickness is regionally variable, 
with wall thicknesses ranging from 1-5+ mm. An average thickness of 3 mm was chosen for ease of 
construction; however, the variable wall thicknesses have clinical significance with regards to 
procedural success and/or adverse events. Thinner areas like the posterior wall and the wall adjacent 
to the ascending aorta are at risk for excessive collateral damage or cardiac perforation. Thicker 
regions such as the ridges between ipsilateral pulmonary veins or at surrounding the opening of the 
atrial appendage may hinder procedural success by requiring increased RF applications and a more 
aggressive heating strategy to generate the ideal depth of lesion needed to prevent AF reconnection 
[84]. As such, the current testbed can assess catheter performance but has less predictive capability 
with assessing procedural success.   
 Ablation Simulation Performance vs Experimental Studies 
 While the lesion dimensions predicted by the 2D and simplified 3D preliminary models were 
close to those reported by Moreno et al [109], lesions generated with the perpendicular electrode 
orientation in the full atrial model were 91.3% narrower and 70% shallower than the experimental 
lesions. The source of this discrepancy is unclear, especially given the same physics, boundary 
conditions and parameters were used for the simplified 3D models. Moreover, ablation with the 
tangentially oriented electrode tip generated lesions that were closer to the experimental study and 
lesions generated in the simplified 3D model, with only -28.5 and +7.9% differences from reported 
max depth and diameter, respectively. Preliminary investigation on the root-cause of this discrepancy 
was carried out in the following studies on the impact of blood velocity on tissue/tip cooling, the 
distribution of current density, and the effect of contact area. 
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 Associated Diagnostic Studies 
6.4.1 Fluid Velocities and Blood Cooling 
 For this test bed, blood motion was included in order to assess thrombogenic potential of a 
catheter design. As expected, in simplifying the anatomical geometry, fluid-structure interaction 
significantly deviated from realistic flows. While realistic flow patterns and velocities were beyond the 
scope of this thesis, initial evaluations suggested that they had a large impact on the lesion outcomes 
[Appendix H]. This is supported by the governing expressions that define heat transfer convective 
coefficients at the electrode-blood interface (hE) and the blood tissue interface (hT), as described by 
Gonzalez-Suarez et al 2016 and others [45]. As velocity field magnitude increases, the degree of 
cooling by the blood also increases. The proportionality relationships of heat transfer coefficient to 
velocity field can be summarized by the following: 
ℎா ∝ 𝑢଴.ସ଺଺ 
ℎ் ∝ 𝑢଴.଼ 
However, these assume Newtonian heat transfer conditions assume a uniform, tangential flow across 
the surface of the tissue, which is not the case in the real atrial model context. Higher resolution 
imaging studies [111] and segmented image computational flow models depict [110] vortices and 
areas of high flow throughout the atrial activation cycle. More heat loss to blood means lower net 
tissue heating, thus leading to reduced lesion sizes. Flow boundary conditions in this model were set 
using an average value for PV inflow velocity from literature. It is not clear whether that velocity 
represented the average velocity, or the luminal velocity found away from the walls. Most importantly 
though, the velocities developed within this left atrial model were for the most part lower than typical 
atrial flow velocities for both healthy and AF hearts. Thus, it is unlikely that excess blood cooling due to 
flow is occurring.  
6.4.2 Contact Area Investigation 
  Contrary to what was expected, tangential lesions produced larger and deeper lesions than 
perpendicular lesions. This does not match experimental studies of electrode orientation, which 
suggested that electrode tips oriented parallel with the tissue surface led to smaller lesions overall 
[87]. The cause of this discrepancy is likely the way electrode contact was modeled. In the 
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perpendicular orientation case, a dish-like indent with a depth of 0.5 mm was formed at the catheter 
contact site as a rough approximation of tissue tenting induced by contact force. Under the 
assumption that less contact force was achievable with the tangential orientation, no such indent was 
applied, with the catheter tip inset minimally (<0.25 mm) into the tissue volume.  
 The effect of contact area was primarily investigated by running an ablation in which the 
conical depression used to simulate tissue tenting was removed. Interestingly, the lesion dimension 
change by omitting the depression and allowing continuous contact with the inserted portion of the 
catheter was miniscule. This suggests that reduced contact area was not responsible for the 
perpendicular/tangential and simple/full 3D model discrepancies. Given that current is a function of 
current density and area, all else held equal, charge traveling between a smaller electrode and a 
larger electrode should result in a higher local current density at the smaller electrode. Thus more 
investigation is still necessary to pinpoint the cause of these anomalous results. 
 Limitations 
 While assumption for homogenous isotropic and parametrically independent material 
domains is generally acceptable for “large” geometries, the inherent anisotropy of tissues coupled 
with multi-parameter dependent material properties means that this assumption may oversimplify the 
real situation. Furthermore, the source of the parameter values also casts uncertainty on their 
appropriateness. Most of the material properties and parameters used in this study were based on ex 
vivo (i.e. non-living and non-perfused) and/or non-human tissues.  
 Core assumptions of the Pennes’ bioheat equation may also contribute to discrepancies 
between experimental and modeled results. This equation assumes that the solution domain is an 
infinite continuous material. With this assumption of macro-continuity, the propagation speed of heat 
is assumed to be instant. However, in cases of high temperatures, high heat fluxes, and short 
durations, the lagging of the heat wave is more apparent. Because of this, there are several alternate 
bioheat models—like the hyperbolic heat transfer model—which take this phenomenon into account. In 
comparative studies of hyperbolic bioheat vs the Pennes’ bioheat equations, lesion size plotted 
against time indicate that the bioheat equation estimates a larger lesion size at t<30 seconds. After 
30 seconds, lesion volume from hyperbolic heat equation overtakes the Pennes’ bioheat lesion 
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estimation, with an estimated 20% difference in lesion size at 60 seconds [112]. Therefore, the 
formulation of the bioheat transfer equation—while likely not a huge contributor—could be 
underestimating lesion sizes. Lastly, better computational resources would enable faster solution 
times, finer meshes, and more complex physical situations.  
 Next Steps 
The most likely remaining culprit has to do with the current density. Dispersive electrodes 
placed on the posterior of the patient are sized such that there is a larger suface area discrepancy 
between the active and dispersive (ground) electrodes. As mentioned in Chapter 3, larger relative 
dispersive electrodes lead to an increase in the current density adjacent to the active electrode. It is 
possible that the boundary representing the posterior face of the tissue block containing the left 
atrium was not large enough. This might be remedied by increasing the side-length of the generic 
tissue block’s posterior face.  
Furthermore, early studies on tissue block sizing performed with the simpler model geometries 
emphasized the impact of separation distance between the active and dispersive electrodes. This is 
somewhat supported by experimental studies on skin electrode placement done for endocardial 
ablations in sheep, where skin electrodes placed directly opposite of the catheter electrode tip 
produce deeper and more consistent lesion depths [113]. 
The tissue is essentially a volumetric resistive domain. With a larger intermediary volume 
between the active and dispersive electrodes, there would be a correspondingly larger impedance 
between them. Following Ohmic relations (V=IR), that would imply that current in the higher 
impedance cases would be lower. While both of these current related suggestions are plausible, they 
do not explain why the tangential electrode positioning performed so well compared with the 
perpendicular electrode position. Thus, more studies are necessary. 
There are several potential improvements for this model that could be implemented. Most 
critically is investigating the causes behind the dramatic decrease in lesion size with the perpendicular 
electrode lesion for the full atrial anatomic model. Another improvement would be implementation of a 
power terminal condition, or voltage titration algorithm to achieve the desired power output. While 
lesion profiles had the correct morphology—i.e. ellipsoids—the observed insufficiency of the 50 V 
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potential assigned to the electrode tip suggests that greater environmental feedback and power 
titration may be necessary. This could be achieved using power- or temperature-controlled ablation 
algorithms. As these algorithms are a critical component of device performance in clinic, emulation of 
these control systems might be the key to producing more realistic lesion dimensions. Once power 
output could be appropriately controlled, parametric properties could be added to the material 
models.  
Geometry-wise, regional wall thicknesses could be altered to emulate their real-life 
counterparts. Currently the wall thickness is set to a uniform 3 mm, but anatomical studies of the left 
atrium indicate that the wall thickness can vary from 1 – 5 mm. Depending on the application of this 
test bed environment, other structure dimensions might need to be customized as well. For example, 
the 4 pulmonary veins in the current model have a circular cross section, with an outer diameter of 15 
mm and an inner diameter of 13 mm. This does not reflect the true diameters of the pulmonary veins, 
where the superior PVs tend to be larger in diameter than the inferior PVs, and the right PVs tend to be 
smaller than the left PVs. Realistic PV orifice dimensions would be of interest when testing balloon-
based catheter ablation systems. 
 While this model was built and tested specifically with the Biosense Webster Thermocool® 
catheter, testing another commercially available catheter tip design and comparing it with the output 
of the model would strengthen the model validity. The ultimate purpose of this model is to aid 
academic research and design of catheter tips through a low-cost, low-variability test bed. Therefore, 
the continuation of this project would be the testing and optimization performance of a novel catheter 
tip design.   
 Finally, the use of this model is not limited to radiofrequency ablation; the bioheat module 
accounts for damage due to tissue heating and freezing. Thus, with some modification of the material 
model to include lower temperature ranges, cryoballoon designs could be tested.  
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 Conclusions 
A 3-dimensional, anatomically relevant, left atrial (LA) test bed for ablation catheter tip 
evaluation was constructed in COMSOL Multiphysics®. The test bed was evaluated using a catheter 
tip based on the Biosense Webster Thermocool® irrigated RF ablation catheter, for a 60 second 
constant 50 V ablation. The morphology of the lesions produced in the atrial testbed had the typical 
ellipsoid shape with surface diameter consistent with the electrode contact area observed in lesion 
studies.  
While the tangentially oriented tip electrodes generated lesions similar to the literature 
comparison study (28.4 and 7.9% difference for max depth and diameter) and the simplified 3D 
ablation case, the perpendicularly oriented electrodes generated 70 – 90% smaller lesions. Possible 
sources of discrepancy include reduced current flow due to larger resistive tissue volumes, the use of 
non-parametric material properties, and neglecting the time-dependence of thermal wave 
propagation. Once discrepancies are accounted for, this testbed could be customized to assess 
performance of other hyper- or hypothermic atrial ablation devices.  
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APPENDICES 
Appendix A. Convergence Testing on Tissue Depth of Simplified Verification Models. 
Tissue 
Block 
Thickness 
Temperature Distribution + Lesion Isotherms Electric Field Norm 
20 mm 
  
30 mm 
  
40 mm 
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50 mm 
  
60 mm 
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Appendix B. Fusion 360 Left Atrial Model 
Several computer aided modeling platforms were trialed to generate the left atrial geometry needed 
for this study. Initial modeling was performed in Fusion 360®, a modeling environment from the 
makers of AutoCAD® and other digital rendering software. Fusion 360® creates geometries with 
classic CAD functions, but also has a GUI and tools to sculpt organic geometries. Using anatomical 
illustrations and CT data stacks, rough initial sketches were produced of different views of the left 
atria and adjacent anatomy. To better visualize the CT stack, the 3D Viewer plugin of ImageJ was 
utilized to provide a rough rendering and greater positional information.  
 
Figure 41. Fusion 360 Left Atrial Model.  
A) Anterior view, B) posterior view, C) superior view, D) inferior view, E) left view, F) right view of left 
atrium. Critical aspects include: pulmonary veins, mitral valve annulus, and left atrial appendage.  
 
To sculpt the left atrium, an obloid rectangle was manually molded in repositioning nodes, boundaries, 
and faces to resemble the left atrial anatomy. This model included the septum, atrial vestibule, left 
atrial appendage, pulmonary veins, and the mitral valve opening.  
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A key advantage of this model was anatomical fidelity. The major issues with this modeling format 
were 
(1) poor reproducibility,  
(2) no customizability of specific regions/dimensions,  
(3) high computational burden, and  
(4) exceedingly long construction times by the modeler. 
  
 98 
Appendix C. COMSOL Multiphysics® CAD Left Atrial Model. 
The next attempt was a simplified version of the left atrium as modeled with the shape “primitives” 
and operations of COMSOL’s native modeling environment. For this model, hollow cylinders were 
attached to a hollow flattened hemisphere to represent the pulmonary veins and atria body. A mitral 
valve opening was formed by differencing away an elliptical cylinder from the posterior aspect of the 
atria body. This entire geometry was then embedded in a block to create domains within the enclosed 
boundaries. Everything beyond the atrial walls was considered a generic external tissue volume, 
whereas everything within the atria was designated as blood volume.   
 
 
This geometry was exceedingly difficult to mesh due to the sharp joins at of the pulmonary veins with 
the atria, as highlighted in the image below [Figure 43Figure]. 
Figure 42. “COMSOL CAD” Left Atrial Model.  
A) Wireframe drawing of head-on mitral valve view. B) 3D wireframe model of the left atria including collateral tissue 
block and defined blood volume.  All dimensions in mm. 
. 
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Figure 43. Mesh of COMSOL CAD Left Atrial Model.  
Sharp interfaces and highly curved geometry led to meshing problems (arrows) that could not be resolved with 
finer meshing. Mesh implemented had tetrahedral shaped elements, with dimensions pre-defined by 
COMSOL under the “Extremely Coarse” element parameter settings.  
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Appendix D. Early SolidWorks® Left Atrial Models 
Shown below are a series of initial atrial models. The main atrial body was created by creating lofts 
between sketched profiles, then shelling the resulting solid. Pulmonary veins were added after. The 
main reason these models were not used for the final assembly was that they could not be imported 
into COMSOL Multiphysics® without an excessive degree of geometry errors. Regardless of filetype, 
those lofted boundaries which made up the exterior of the main atrial boundary were treated as 
discontinuous or intersecting surfaces by COMSOL. While efforts were made to address those 
geometry errors, it was determined that reworking the design in SolidWorks® was easier and a more 
effective use of time than trying to resolve the errors with COMSOL’s limited solid modeling tools. 
 
 
Figure 44. Early Atrial Models with 2 Planes of Symmetry. 
Figure 45. Early SolidWorks Model with 1 Plane of Symmetry. 
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Figure 46. Interior View of Early Atrial Models with 2 Planes of Symmetry. 
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Appendix E. Final Left Atrial SolidWorks® Model 
The following images contain critical dimensions and several views of the left atrial assembly 
developed in SolidWorks ®. 
 
Figure 47. Dimensioned Top View of Left Atrial Model. 
 
  
Figure 48. Alternate Views of Left Atrial Assembly.  
Views taken from the left posterior perspective (left) and left anterior perspective (right).  
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Figure 49. Posterior (left) and Inferior (right) Views of Left Atrial Assembly 
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Appendix F. Protocol for Pre-processing and Transfer of Complex Geometric Models 
from SolidWorks to COMSOL. 
Catheter Design Addition 
1. If adding a catheter tip design to the model, import it into the assembly and position first 
using the Mate tools. It will be a lot easier to do this in SolidWorks than in COMSOL.  
Defeaturing and Geometry Checks 
1. As much as possible, merge small faces to form larger curved surfaces using the “Delete 
Faces” tool in SolidWorks. 
2. Run Geometry Analysis to identify any short edges, knife angles, etc. are in each part. Resolve 
these in SolidWorks.  
Exporting the Assembly from SolidWorks® 
1. Once the assembly is ready to be moved over to COMSOL, export it as a Parasolid binary 
(.x_b) file type. (Note: The filetypes that seemed to have the greatest chances of transfer 
success are .x_b, .x_t, .stl). 
Importing the Assembly to COMSOL 
1. Use the “Import” tool to import in the assembly files. Specify appropriate dimension scale in 
“Geometry” model tree settings.  
Building the Mesh 
1. If error messages about thin element sizes come up during the message process, the 
merge tools of the “Virtual Operations” toolbar can be particularly useful. 
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Appendix G. Material Domain Definitions in Left Atrial Model. 
 
Figure 50. "Generic Tissue" Domain in Full Model. 
 
 
Figure 51. Myocardium Domain in Full Model. 
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Figure 52. Blood Domains in Full Model. 
 
To simplify the solution, the aortal blood volume was removed as a domain from the simulations, and 
a 37 °C boundary condition was placed on the interior surface of the aorta. 
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Figure 53. Catheter Tip in COMSOL Model 
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Appendix H. Physics Verification Studies: Effect of Blood Flow, Saline Irrigation, and Temperature-Dependent Properties 
Effect of Blood Flow on Lesion Morphology 
 
Figure 54. Lesion Morphology in Simulations with and without Blood Flow. 
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Effect of Irrigation on Lesion Production 
 
Figure 55. Temperature Distribution after 60s of 50V Constant Voltage Ablation Without Irrigation (A), and With Irrigation of 30 mL/min (B). 
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Figure 56. Damage Distribution after 60s of 50V Constant Voltage Ablation Without Irrigation (A), and With Irrigation of 30 mL/min (B). 
 
Static Material Properties vs Temperature Dependent Material Properties 
 As expected, implementation of rudimentary temperature dependence of material properties produced a smaller lesion size than the static case, 
as depicted in [Figure 57]. The maximum depth and diameter of the temperature dependent lesion case was 5.6 mm and 8.0 mm, respectively. On the 
other hand, the static material properties predicted a lesion with a max depth of 6.9 mm, and a max diameter of 11.1 mm.  
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Figure 57. Effect of Temperature Dependent Properties on Lesion Production.  
Damage plotted to show extent of lesion propagation. 
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Appendix I. Preliminary Flow Studies in the Left Atrial Model. 
 While realistic flow patterns were not deemed critical to model success for this thesis, 
selected velocity measurements were used to check the suitability of the PV inflow condition. Average 
blood velocity and transmitral flow velocity were sampled using domain and boundary averaging 
methods, respectively. These values were compared against blood velocities of patients with AF 
determined by Doppler electrocardiography, the results of which are summarized in the table below 
[Table 10]. 
Table 10. Simulated Blood Flow vs Clinical Velocities from Doppler Echocardiography. 
 
Parameter Literature Value Integrated 
Transmitral 
Flow Value 
Large Model % 
Difference 
Blood Flow Velocity 
(Entire R-R Interval) 0.13 ± 0.02 m/s 0.082 m/s -36.9% 
Transmitral Flow Velocity 0.30 ± 0.10 m/s 0.211 m/s -29.8% 
 
Based on the sampled velocity values, it appeared that the 0.2 m/s velocity condition set on the PV 
inlets was too low to achieve adequate overall flow velocity.  
 Initial modeling with the 0.20 m/s inflow condition on the pulmonary veins produced 
velocities that were not consistent with those observed in clinic for AF patients. To address this, a 
parametric study was performed on PV inflow velocity with values ranging from 0.2 – 0.8 m/s. When 
compared with the target average velocity and transmitral flow, 0.3 m/s generated percent differences 
of 8.5% and 1.2% respectively [Table 11]. 
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Table 11. Parametric Study on Inlet Velocities to Match Clinical Data for AF Patients.  
Values of transmitral and average left atrial blood velocities determined by Doppler echocardiography 
[105] 
PV Inlet 
Velocity 
[m/s] 
Transmitral 
Flow [m/s] 
Target, 
Transmitral 
Velocity 
% Difference 
from Target 
Average LA 
Velocity, 
[m/s] 
Target, Avg 
LA Velocity 
% Difference 
from Target 
0.2 0.21 0.30 -29.8% 0.08 0.13 -36.9% 
0.3 0.30 0.30 1.2% 0.12 0.13 -8.5% 
0.4 0.39 0.30 31.1% 0.16 0.13 19.4% 
0.5 0.48 0.30 60.5% 0.19 0.13 47.3% 
0.6 0.57 0.30 89.5% 0.23 0.13 75.1% 
0.7 0.65 0.30 118.0% 0.26 0.13 102.8% 
0.8 0.74 0.30 146.2% 0.30 0.13 130.6% 
 
But while the overall velocity profiles were closer to physiologic values with this modification, the 
lesion dimensions were at least 15% smaller than the previous flow case [Table 8]. This decrease in 
lesion size with higher flow rates was expected, with faster flow corresponding with greater convective 
cooling. 
Table 12. Lesion Dimension Comparison with Different PV Velocities.  
All velocities reported in [m/s].  
 Lesion Max 
Depth [mm] 
Lesion Max 
Width [mm] 
Moreno et al 9.3 ± 1.4 10.3 ± 1.5 
0.20 m/s 1.040 3.993 
0.30 m/s 0.879 3.042 
 
More importantly, none of these flow cases resulted lesion dimensions commensurate with the 
experimental dimensions. 
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Appendix J. Exploratory Characterization of Activation Energy Value Effect on Damage 
Quantification. 
  
Figure 58. Damage Evaluation Comparison, with Parametric Sweep of Activation Energy. 
 
 
